NIK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O14920 | S177 | PSP | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O15111 | S176 | SIGNOR|iPTMNet|PSP | CHUK IKKA TCF16 | GGKIIHKIIDLGYAKDVDQGsLCTsFVGTLQYLAPELFENK |
| O15111 | S180 | SIGNOR|iPTMNet|PSP | CHUK IKKA TCF16 | IHKIIDLGYAKDVDQGsLCTsFVGTLQYLAPELFENKPYTA |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P11413 | S278 | PSP | G6PD | DVMQNHLLQMLCLVAMEKPAsTNSDDVRDEKVKVLKCISEV |
| P11413 | S40 | SIGNOR|PSP | G6PD | LFQGDAFHQSDTHIFIIMGAsGDLAKKKIYPTIWWLFRDGL |
| P11413 | S486 | PSP | G6PD | tPLLHQIELEKPKPIPYIYGsRGPTEADELMKRVGFQyEGt |
| P11413 | S8 | PSP | G6PD | _____________MAEQVALsRtQVCGILREELFQGDAFHQ |
| P12277 | T322 | Sugiyama | CKB CKBB | LGKHEKFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRL |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P25963 | S32 | PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S36 | PSP | NFKBIA IKBA MAD3 NFKBI | PRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEIRLEP |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P61160 | T237 | PSP | ACTR2 ARP2 | KEKLCYVGYNIEQEQKLALEttVLVESYTLPDGRIIKVGGE |
| P61160 | T238 | PSP | ACTR2 ARP2 | EKLCYVGYNIEQEQKLALEttVLVESYTLPDGRIIKVGGER |
| P61160 | Y202 | PSP | ACTR2 ARP2 | LDIAGRDITRYLIKLLLLRGyAFNHSADFETVRMIKEKLCY |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q00653 | S866 | SIGNOR|ELM|iPTMNet|EPSD|PSP | NFKB2 LYT10 | LLRGPETRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEP |
| Q00653 | S870 | SIGNOR|ELM|iPTMNet|EPSD|PSP | NFKB2 LYT10 | PETRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEPPGGL |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q99558 | S410 | Sugiyama | MAP3K14 NIK | DYEYREEVHWATHQLRLGRGsFGEVHRMEDKQTGFQCAVKK |
| Q99558 | S826 | Sugiyama | MAP3K14 NIK | SDDSEKNPsKAsQSsRDTLSsGVHsWSSQAEARSSsWNMVL |
| Q99558 | S830 | Sugiyama | MAP3K14 NIK | EKNPsKAsQSsRDTLSsGVHsWSSQAEARSSsWNMVLARGR |
| Q99558 | S841 | Sugiyama | MAP3K14 NIK | RDTLSsGVHsWSSQAEARSSsWNMVLARGRPTDtPsyFNGV |
| Q99558 | S856 | Sugiyama | MAP3K14 NIK | EARSSsWNMVLARGRPTDtPsyFNGVKVQIQSLNGEHLHIR |
| Q99558 | T685 | Sugiyama | MAP3K14 NIK | WRGEYKEPRHPPPNQANyHQtLHAQPRELSPRAPGPRPAEE |
| Q99558 | T854 | Sugiyama | MAP3K14 NIK | QAEARSSsWNMVLARGRPTDtPsyFNGVKVQIQSLNGEHLH |
| Q99558 | Y682 | Sugiyama | MAP3K14 NIK | KSPWRGEYKEPRHPPPNQANyHQtLHAQPRELSPRAPGPRP |
| Q99558 | Y857 | Sugiyama | MAP3K14 NIK | ARSSsWNMVLARGRPTDtPsyFNGVKVQIQSLNGEHLHIRE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.756464e-10 | 9.425 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.933116e-10 | 9.159 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.402168e-09 | 8.619 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.315107e-09 | 8.200 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.066488e-08 | 7.093 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.068730e-07 | 6.971 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.480873e-07 | 6.605 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.782379e-07 | 6.422 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.317706e-07 | 6.031 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.104291e-06 | 5.957 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.899883e-06 | 5.721 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.047325e-06 | 5.689 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.984372e-06 | 5.525 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.637033e-06 | 5.334 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.846234e-06 | 5.315 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.471152e-06 | 5.262 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.651918e-06 | 5.177 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.569234e-06 | 5.019 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.212167e-05 | 4.916 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.327325e-05 | 4.877 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.375658e-05 | 4.861 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.918062e-05 | 4.717 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.918062e-05 | 4.717 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.819501e-05 | 4.740 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.186459e-05 | 4.660 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.786528e-05 | 4.555 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.302743e-05 | 4.481 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.803423e-05 | 4.420 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.954680e-05 | 4.403 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.021257e-05 | 4.396 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.240859e-05 | 4.373 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.509254e-05 | 4.346 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.073292e-05 | 4.295 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.425080e-05 | 4.266 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.671713e-05 | 4.246 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.702386e-05 | 4.174 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.788154e-05 | 4.056 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.220542e-05 | 4.035 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.990635e-05 | 4.000 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.020859e-04 | 3.991 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.119306e-04 | 3.951 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.292433e-04 | 3.889 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.522056e-04 | 3.818 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.731607e-04 | 3.762 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.221580e-04 | 3.653 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.281056e-04 | 3.642 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.479911e-04 | 3.606 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.196812e-04 | 3.495 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.950267e-04 | 3.403 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.950267e-04 | 3.403 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.996344e-04 | 3.398 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.146291e-04 | 3.382 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.261545e-04 | 3.370 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.891716e-04 | 3.311 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.891716e-04 | 3.311 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.891716e-04 | 3.311 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.169570e-04 | 3.287 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.186092e-04 | 3.285 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.837859e-04 | 3.315 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.185077e-04 | 3.285 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.209147e-04 | 3.283 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.688553e-04 | 3.329 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.538701e-04 | 3.257 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.538701e-04 | 3.257 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.373846e-04 | 3.270 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.524045e-04 | 3.258 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.526946e-04 | 3.258 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.069919e-04 | 3.217 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.202485e-04 | 3.207 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.016824e-04 | 3.221 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.961099e-04 | 3.157 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.200188e-04 | 3.143 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.241387e-04 | 3.084 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.156097e-04 | 3.089 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.375395e-04 | 3.077 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 8.652078e-04 | 3.063 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.848334e-04 | 3.053 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.042373e-04 | 3.044 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.608679e-04 | 3.017 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.094145e-03 | 2.961 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.163526e-03 | 2.934 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.226016e-03 | 2.912 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.259135e-03 | 2.900 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.277917e-03 | 2.893 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.292802e-03 | 2.888 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.301547e-03 | 2.886 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.409295e-03 | 2.851 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.357587e-03 | 2.867 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.414047e-03 | 2.850 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.394609e-03 | 2.856 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.432566e-03 | 2.844 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.432566e-03 | 2.844 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.445244e-03 | 2.840 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.516670e-03 | 2.819 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.656259e-03 | 2.781 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.656259e-03 | 2.781 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.656259e-03 | 2.781 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.656259e-03 | 2.781 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.666210e-03 | 2.778 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.671351e-03 | 2.777 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.815779e-03 | 2.741 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.929437e-03 | 2.715 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.947369e-03 | 2.711 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.147550e-03 | 2.668 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.022596e-03 | 2.694 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.155600e-03 | 2.666 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.180397e-03 | 2.661 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.224846e-03 | 2.653 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.224846e-03 | 2.653 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.252523e-03 | 2.647 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.516356e-03 | 2.599 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.539658e-03 | 2.595 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.351403e-03 | 2.629 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.539658e-03 | 2.595 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.555149e-03 | 2.593 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.555149e-03 | 2.593 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.555149e-03 | 2.593 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.555149e-03 | 2.593 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.576169e-03 | 2.589 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.812083e-03 | 2.551 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.665196e-03 | 2.574 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.722002e-03 | 2.565 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.812083e-03 | 2.551 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.903586e-03 | 2.537 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.923159e-03 | 2.534 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.950354e-03 | 2.530 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.103431e-03 | 2.508 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.137595e-03 | 2.503 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.214208e-03 | 2.493 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.383553e-03 | 2.471 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.425395e-03 | 2.465 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.479941e-03 | 2.458 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.487425e-03 | 2.457 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.851883e-03 | 2.414 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.860940e-03 | 2.413 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.054711e-03 | 2.392 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.218978e-03 | 2.375 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.282992e-03 | 2.368 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.387421e-03 | 2.358 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.533644e-03 | 2.344 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.807777e-03 | 2.318 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.831822e-03 | 2.316 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.831822e-03 | 2.316 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.277979e-03 | 2.278 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.752321e-03 | 2.240 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.181805e-03 | 2.286 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.265024e-03 | 2.279 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.433876e-03 | 2.265 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.410215e-03 | 2.267 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.901092e-03 | 2.229 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.007669e-03 | 2.221 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.022775e-03 | 2.220 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.022775e-03 | 2.220 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.117754e-03 | 2.213 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.688101e-03 | 2.175 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.915728e-03 | 2.160 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.059491e-03 | 2.151 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.098013e-03 | 2.149 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.369306e-03 | 2.133 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.809559e-03 | 2.107 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.825219e-03 | 2.107 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.090917e-03 | 2.092 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.896292e-03 | 2.051 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.289116e-03 | 2.081 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.090899e-03 | 2.092 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.090917e-03 | 2.092 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.637323e-03 | 2.064 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.174895e-03 | 2.088 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.028323e-03 | 2.044 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.041617e-03 | 2.044 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.494514e-03 | 2.023 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.539686e-03 | 2.020 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.683394e-03 | 2.014 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.003550e-02 | 1.998 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.066619e-02 | 1.972 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.066619e-02 | 1.972 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.263602e-02 | 1.898 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.187789e-02 | 1.925 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.141633e-02 | 1.942 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.168349e-02 | 1.932 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.151147e-02 | 1.939 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.229019e-02 | 1.910 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.229019e-02 | 1.910 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.249869e-02 | 1.903 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.249944e-02 | 1.903 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.263602e-02 | 1.898 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.189447e-02 | 1.925 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.217085e-02 | 1.915 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.250056e-02 | 1.903 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.188494e-02 | 1.925 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.256484e-02 | 1.901 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.274537e-02 | 1.895 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.274537e-02 | 1.895 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.338525e-02 | 1.873 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.389209e-02 | 1.857 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.454893e-02 | 1.837 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.463646e-02 | 1.835 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.475102e-02 | 1.831 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.475102e-02 | 1.831 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.475102e-02 | 1.831 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.502503e-02 | 1.823 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.502503e-02 | 1.823 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.511668e-02 | 1.821 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.518443e-02 | 1.819 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.559261e-02 | 1.807 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.559261e-02 | 1.807 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.563107e-02 | 1.806 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.563107e-02 | 1.806 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.676376e-02 | 1.776 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.617147e-02 | 1.791 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.680293e-02 | 1.775 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.781940e-02 | 1.749 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.617147e-02 | 1.791 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.726009e-02 | 1.763 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.835226e-02 | 1.736 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.746765e-02 | 1.758 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.746765e-02 | 1.758 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.677130e-02 | 1.775 | 1 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.868941e-02 | 1.728 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.903768e-02 | 1.720 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.903768e-02 | 1.720 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.903768e-02 | 1.720 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.903768e-02 | 1.720 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.903768e-02 | 1.720 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.917372e-02 | 1.717 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.917372e-02 | 1.717 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.958441e-02 | 1.708 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.960172e-02 | 1.708 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.998604e-02 | 1.699 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.003657e-02 | 1.698 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.070193e-02 | 1.684 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.122433e-02 | 1.673 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.122433e-02 | 1.673 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.203227e-02 | 1.657 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.203227e-02 | 1.657 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.249776e-02 | 1.648 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.249776e-02 | 1.648 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.376356e-02 | 1.624 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 2.376356e-02 | 1.624 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.385781e-02 | 1.622 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.402161e-02 | 1.619 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.402161e-02 | 1.619 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.430242e-02 | 1.614 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.810047e-02 | 1.551 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.770876e-02 | 1.557 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.777946e-02 | 1.556 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.916280e-02 | 1.535 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.804988e-02 | 1.552 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.667197e-02 | 1.574 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.843641e-02 | 1.546 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.745423e-02 | 1.561 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.642929e-02 | 1.578 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.789341e-02 | 1.554 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.713879e-02 | 1.566 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.713879e-02 | 1.566 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.969604e-02 | 1.527 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.971361e-02 | 1.527 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.971361e-02 | 1.527 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.971361e-02 | 1.527 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.006153e-02 | 1.522 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.066434e-02 | 1.513 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.228522e-02 | 1.491 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.297415e-02 | 1.482 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.355054e-02 | 1.474 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.399314e-02 | 1.469 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.399314e-02 | 1.469 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.496368e-02 | 1.456 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.496368e-02 | 1.456 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.661203e-02 | 1.436 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.661203e-02 | 1.436 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.701683e-02 | 1.432 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.701683e-02 | 1.432 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.822926e-02 | 1.418 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.822926e-02 | 1.418 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.836986e-02 | 1.416 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.937770e-02 | 1.405 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.985209e-02 | 1.400 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.016961e-02 | 1.396 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.077018e-02 | 1.390 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.115606e-02 | 1.386 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.115606e-02 | 1.386 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.148748e-02 | 1.382 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.148748e-02 | 1.382 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.148748e-02 | 1.382 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.953171e-02 | 1.305 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.953171e-02 | 1.305 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.953171e-02 | 1.305 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.953171e-02 | 1.305 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.953171e-02 | 1.305 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.260918e-02 | 1.370 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.101756e-02 | 1.292 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.870475e-02 | 1.312 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.762981e-02 | 1.322 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.376648e-02 | 1.359 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.870475e-02 | 1.312 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.260918e-02 | 1.370 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.953171e-02 | 1.305 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.300645e-02 | 1.276 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.953171e-02 | 1.305 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.870475e-02 | 1.312 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.748658e-02 | 1.323 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.931953e-02 | 1.307 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.277388e-02 | 1.369 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.762981e-02 | 1.322 | 1 | 1 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.260918e-02 | 1.370 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.870475e-02 | 1.312 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.067145e-02 | 1.295 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.067145e-02 | 1.295 | 1 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.263414e-02 | 1.370 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.326902e-02 | 1.274 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.326902e-02 | 1.274 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.385146e-02 | 1.269 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.412263e-02 | 1.267 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.465171e-02 | 1.262 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.465171e-02 | 1.262 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.479137e-02 | 1.261 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.522643e-02 | 1.258 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.597781e-02 | 1.252 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.613908e-02 | 1.251 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.633218e-02 | 1.249 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 5.723190e-02 | 1.242 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 5.723190e-02 | 1.242 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 5.723190e-02 | 1.242 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.723190e-02 | 1.242 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.723190e-02 | 1.242 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 5.723190e-02 | 1.242 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 5.723190e-02 | 1.242 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 5.723190e-02 | 1.242 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 5.723190e-02 | 1.242 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 5.723190e-02 | 1.242 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 5.723190e-02 | 1.242 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 5.723190e-02 | 1.242 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.723254e-02 | 1.242 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.723254e-02 | 1.242 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.734802e-02 | 1.241 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.750757e-02 | 1.240 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.828131e-02 | 1.234 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.853997e-02 | 1.233 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.983582e-02 | 1.223 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.016374e-02 | 1.221 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.490841e-02 | 1.188 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.490841e-02 | 1.188 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.490841e-02 | 1.188 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.490841e-02 | 1.188 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.001809e-02 | 1.155 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.001809e-02 | 1.155 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.001809e-02 | 1.155 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.001809e-02 | 1.155 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.001809e-02 | 1.155 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.001809e-02 | 1.155 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.001809e-02 | 1.155 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.054721e-02 | 1.094 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.054721e-02 | 1.094 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.219469e-02 | 1.206 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.960297e-02 | 1.157 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.744275e-02 | 1.111 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.744275e-02 | 1.111 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.744275e-02 | 1.111 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.832527e-02 | 1.106 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.773462e-02 | 1.169 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.247872e-02 | 1.140 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.244665e-02 | 1.204 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.244665e-02 | 1.204 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.512315e-02 | 1.124 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.210675e-02 | 1.142 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.520300e-02 | 1.186 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.658028e-02 | 1.177 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.036349e-02 | 1.095 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.001809e-02 | 1.155 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.001809e-02 | 1.155 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.244665e-02 | 1.204 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.001809e-02 | 1.155 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.660027e-02 | 1.116 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.054721e-02 | 1.094 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.036349e-02 | 1.095 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.966885e-02 | 1.099 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.054721e-02 | 1.094 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.210675e-02 | 1.142 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.054721e-02 | 1.094 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.911448e-02 | 1.160 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.704949e-02 | 1.113 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.284169e-02 | 1.202 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.744275e-02 | 1.111 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.832527e-02 | 1.106 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.272420e-02 | 1.138 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.054721e-02 | 1.094 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.219469e-02 | 1.206 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.736049e-02 | 1.172 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.439792e-02 | 1.191 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.744275e-02 | 1.111 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.490841e-02 | 1.188 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.744275e-02 | 1.111 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.181604e-02 | 1.209 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.090264e-02 | 1.149 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.237843e-02 | 1.140 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.179311e-02 | 1.209 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.163869e-02 | 1.088 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 8.163869e-02 | 1.088 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.163869e-02 | 1.088 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.272829e-02 | 1.082 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.332182e-02 | 1.079 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.332182e-02 | 1.079 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.332182e-02 | 1.079 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.416225e-02 | 1.075 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.786000e-02 | 1.056 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.786000e-02 | 1.056 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.786000e-02 | 1.056 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.786000e-02 | 1.056 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.973470e-02 | 1.047 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.023315e-02 | 1.045 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.171482e-02 | 1.038 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.171482e-02 | 1.038 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.336752e-02 | 1.030 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.426510e-02 | 1.026 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.653542e-02 | 1.015 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 9.951761e-02 | 1.002 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.951761e-02 | 1.002 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.029649e-01 | 0.987 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.034405e-01 | 0.985 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.034405e-01 | 0.985 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.034824e-01 | 0.985 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.034824e-01 | 0.985 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.034824e-01 | 0.985 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.034824e-01 | 0.985 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.047886e-01 | 0.980 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.047886e-01 | 0.980 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.111916e-01 | 0.954 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.111916e-01 | 0.954 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.111916e-01 | 0.954 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.111916e-01 | 0.954 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.111916e-01 | 0.954 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.111916e-01 | 0.954 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.111916e-01 | 0.954 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.183592e-01 | 0.927 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.183592e-01 | 0.927 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 1.183592e-01 | 0.927 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.183592e-01 | 0.927 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.183592e-01 | 0.927 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.183592e-01 | 0.927 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.379950e-01 | 0.860 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.379950e-01 | 0.860 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.379950e-01 | 0.860 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.582726e-01 | 0.801 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.582726e-01 | 0.801 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.582726e-01 | 0.801 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.158097e-01 | 0.936 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.158097e-01 | 0.936 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.158097e-01 | 0.936 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 1.286556e-01 | 0.891 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.419782e-01 | 0.848 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.557354e-01 | 0.808 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.328647e-01 | 0.877 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.328647e-01 | 0.877 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.328647e-01 | 0.877 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.433590e-01 | 0.844 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.433590e-01 | 0.844 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.541668e-01 | 0.812 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.541668e-01 | 0.812 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.384459e-01 | 0.859 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.473834e-01 | 0.832 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.357362e-01 | 0.867 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.541668e-01 | 0.812 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.473834e-01 | 0.832 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.473834e-01 | 0.832 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.473834e-01 | 0.832 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.359625e-01 | 0.867 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.473834e-01 | 0.832 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.154367e-01 | 0.938 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.557354e-01 | 0.808 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 1.286556e-01 | 0.891 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.328647e-01 | 0.877 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.582726e-01 | 0.801 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.557354e-01 | 0.808 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.286556e-01 | 0.891 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.183592e-01 | 0.927 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.183592e-01 | 0.927 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.384459e-01 | 0.859 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.370596e-01 | 0.863 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.557354e-01 | 0.808 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.379950e-01 | 0.860 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 1.110107e-01 | 0.955 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.172580e-01 | 0.931 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.227020e-01 | 0.911 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.270932e-01 | 0.896 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.468122e-01 | 0.833 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.582726e-01 | 0.801 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.379950e-01 | 0.860 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.419782e-01 | 0.848 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 1.557354e-01 | 0.808 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 1.582726e-01 | 0.801 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.244070e-01 | 0.905 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.231354e-01 | 0.910 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.286556e-01 | 0.891 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.111916e-01 | 0.954 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.183592e-01 | 0.927 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.379950e-01 | 0.860 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.557354e-01 | 0.808 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.128883e-01 | 0.947 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.541668e-01 | 0.812 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.313931e-01 | 0.881 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.110107e-01 | 0.955 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.195632e-01 | 0.922 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.565592e-01 | 0.805 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.276918e-01 | 0.894 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.582726e-01 | 0.801 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.286556e-01 | 0.891 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.433590e-01 | 0.844 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.541668e-01 | 0.812 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.158097e-01 | 0.936 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.128883e-01 | 0.947 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.379950e-01 | 0.860 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.582726e-01 | 0.801 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.582726e-01 | 0.801 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.433590e-01 | 0.844 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.213251e-01 | 0.916 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.419782e-01 | 0.848 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.058708e-01 | 0.975 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.126310e-01 | 0.948 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.582726e-01 | 0.801 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.464316e-01 | 0.834 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.254701e-01 | 0.901 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.183592e-01 | 0.927 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.183592e-01 | 0.927 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.328647e-01 | 0.877 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.102772e-01 | 0.958 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.359625e-01 | 0.867 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.276918e-01 | 0.894 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.594308e-01 | 0.797 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 1.620659e-01 | 0.790 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.620659e-01 | 0.790 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 1.620659e-01 | 0.790 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 1.620659e-01 | 0.790 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.620659e-01 | 0.790 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.620659e-01 | 0.790 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.620659e-01 | 0.790 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 1.620659e-01 | 0.790 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 1.620659e-01 | 0.790 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.620659e-01 | 0.790 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.620659e-01 | 0.790 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.646271e-01 | 0.783 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.652694e-01 | 0.782 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.652694e-01 | 0.782 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.652694e-01 | 0.782 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.652694e-01 | 0.782 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.652694e-01 | 0.782 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.652694e-01 | 0.782 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.657994e-01 | 0.780 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.657994e-01 | 0.780 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.659629e-01 | 0.780 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.659629e-01 | 0.780 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.659629e-01 | 0.780 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.675215e-01 | 0.776 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.675215e-01 | 0.776 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.675215e-01 | 0.776 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.698853e-01 | 0.770 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.698853e-01 | 0.770 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.698853e-01 | 0.770 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.100311e-01 | 0.678 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.100311e-01 | 0.678 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.100311e-01 | 0.678 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.100311e-01 | 0.678 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.100311e-01 | 0.678 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 2.100311e-01 | 0.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.100311e-01 | 0.678 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 2.552535e-01 | 0.593 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.552535e-01 | 0.593 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.552535e-01 | 0.593 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.552535e-01 | 0.593 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.552535e-01 | 0.593 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.978896e-01 | 0.526 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.978896e-01 | 0.526 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.790545e-01 | 0.747 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.002166e-01 | 0.698 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.002166e-01 | 0.698 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 2.002166e-01 | 0.698 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.002166e-01 | 0.698 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.002166e-01 | 0.698 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.002166e-01 | 0.698 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.002166e-01 | 0.698 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.002166e-01 | 0.698 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.380872e-01 | 0.471 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.380872e-01 | 0.471 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 3.380872e-01 | 0.471 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.216476e-01 | 0.654 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.216476e-01 | 0.654 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.216476e-01 | 0.654 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.843864e-01 | 0.734 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.843864e-01 | 0.734 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.843864e-01 | 0.734 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.843864e-01 | 0.734 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 2.649268e-01 | 0.577 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 1.991979e-01 | 0.701 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.142798e-01 | 0.669 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 2.866058e-01 | 0.543 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.866058e-01 | 0.543 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.295934e-01 | 0.639 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.082137e-01 | 0.511 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.082137e-01 | 0.511 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.082137e-01 | 0.511 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.082137e-01 | 0.511 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 3.082137e-01 | 0.511 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.082137e-01 | 0.511 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.451010e-01 | 0.611 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.607664e-01 | 0.584 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.296875e-01 | 0.482 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.296875e-01 | 0.482 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.765548e-01 | 0.558 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.160141e-01 | 0.666 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.623674e-01 | 0.581 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.243331e-01 | 0.489 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.243331e-01 | 0.489 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.402964e-01 | 0.468 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.293389e-01 | 0.482 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.369880e-01 | 0.625 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.369880e-01 | 0.625 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.082137e-01 | 0.511 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.854109e-01 | 0.732 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.766476e-01 | 0.753 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.243331e-01 | 0.489 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.330688e-01 | 0.633 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.852538e-01 | 0.732 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.790545e-01 | 0.747 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.082137e-01 | 0.511 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.135162e-01 | 0.504 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.790545e-01 | 0.747 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.790545e-01 | 0.747 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.991979e-01 | 0.701 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.245257e-01 | 0.649 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.924329e-01 | 0.534 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.245257e-01 | 0.649 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.924329e-01 | 0.534 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.122408e-01 | 0.673 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.978896e-01 | 0.526 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.216476e-01 | 0.654 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.766476e-01 | 0.753 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.001529e-01 | 0.699 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.001529e-01 | 0.699 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.767496e-01 | 0.753 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.145013e-01 | 0.502 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.432475e-01 | 0.614 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.002166e-01 | 0.698 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 3.082137e-01 | 0.511 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.001529e-01 | 0.699 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.765548e-01 | 0.558 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.765548e-01 | 0.558 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.765548e-01 | 0.558 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.056377e-01 | 0.687 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.886401e-01 | 0.724 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.480524e-01 | 0.605 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.012889e-01 | 0.521 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.832352e-01 | 0.548 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 2.362674e-01 | 0.627 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.002166e-01 | 0.698 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.489264e-01 | 0.604 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.380872e-01 | 0.471 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.082137e-01 | 0.511 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 3.082137e-01 | 0.511 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 1.882820e-01 | 0.725 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.122408e-01 | 0.673 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.122408e-01 | 0.673 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.133386e-01 | 0.671 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.036244e-01 | 0.691 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.439949e-01 | 0.613 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.919838e-01 | 0.717 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.231021e-01 | 0.491 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.100311e-01 | 0.678 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.100311e-01 | 0.678 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.100311e-01 | 0.678 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.552535e-01 | 0.593 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.002166e-01 | 0.698 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.380872e-01 | 0.471 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.216476e-01 | 0.654 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 2.216476e-01 | 0.654 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.216476e-01 | 0.654 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.216476e-01 | 0.654 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.432475e-01 | 0.614 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 2.649268e-01 | 0.577 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 2.866058e-01 | 0.543 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.082137e-01 | 0.511 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.122408e-01 | 0.673 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.245257e-01 | 0.649 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.245257e-01 | 0.649 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.752461e-01 | 0.560 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.107102e-01 | 0.508 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.607664e-01 | 0.584 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 2.496083e-01 | 0.603 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.245257e-01 | 0.649 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.369880e-01 | 0.625 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.496083e-01 | 0.603 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.432475e-01 | 0.614 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.432475e-01 | 0.614 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.432475e-01 | 0.614 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.001529e-01 | 0.699 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 1.954327e-01 | 0.709 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.790545e-01 | 0.747 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.847558e-01 | 0.733 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.432475e-01 | 0.614 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 3.296875e-01 | 0.482 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.402964e-01 | 0.468 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.847558e-01 | 0.733 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.158350e-01 | 0.501 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.012889e-01 | 0.521 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.012889e-01 | 0.521 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.432475e-01 | 0.614 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 2.446129e-01 | 0.612 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 2.100311e-01 | 0.678 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.552535e-01 | 0.593 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.978896e-01 | 0.526 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.790545e-01 | 0.747 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.380872e-01 | 0.471 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 2.649268e-01 | 0.577 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.001529e-01 | 0.699 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.607664e-01 | 0.584 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.402964e-01 | 0.468 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.127840e-01 | 0.672 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.082137e-01 | 0.511 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.924839e-01 | 0.716 | 1 | 0 |
| Histamine receptors | R-HSA-390650 | 2.552535e-01 | 0.593 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.924329e-01 | 0.534 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.623674e-01 | 0.581 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.050271e-01 | 0.688 | 1 | 0 |
| Ion channel transport | R-HSA-983712 | 1.734862e-01 | 0.761 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.082137e-01 | 0.511 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.100311e-01 | 0.678 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.552535e-01 | 0.593 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.552535e-01 | 0.593 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.978896e-01 | 0.526 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.380872e-01 | 0.471 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.649268e-01 | 0.577 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.649268e-01 | 0.577 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.296875e-01 | 0.482 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.296875e-01 | 0.482 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.083691e-01 | 0.511 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.402964e-01 | 0.468 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.932616e-01 | 0.533 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.991979e-01 | 0.701 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.369880e-01 | 0.625 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.798811e-01 | 0.553 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.391423e-01 | 0.470 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.001529e-01 | 0.699 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.107102e-01 | 0.508 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.432475e-01 | 0.614 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.296875e-01 | 0.482 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.095852e-01 | 0.509 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.380872e-01 | 0.471 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 2.649268e-01 | 0.577 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.451010e-01 | 0.611 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.988176e-01 | 0.702 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.988176e-01 | 0.702 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.988176e-01 | 0.702 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.919838e-01 | 0.717 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.876924e-01 | 0.541 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.876924e-01 | 0.541 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.487022e-01 | 0.604 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.866058e-01 | 0.543 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.194708e-01 | 0.496 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.924329e-01 | 0.534 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.380872e-01 | 0.471 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.296875e-01 | 0.482 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.644458e-01 | 0.578 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.866058e-01 | 0.543 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 2.122408e-01 | 0.673 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.790545e-01 | 0.747 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.023270e-01 | 0.694 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.490208e-01 | 0.604 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.607664e-01 | 0.584 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.407999e-01 | 0.468 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.407999e-01 | 0.468 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.407999e-01 | 0.468 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.407999e-01 | 0.468 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.437545e-01 | 0.464 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.509720e-01 | 0.455 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.509720e-01 | 0.455 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.509720e-01 | 0.455 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.509720e-01 | 0.455 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.562323e-01 | 0.448 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.610852e-01 | 0.442 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.718963e-01 | 0.430 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.720183e-01 | 0.429 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.720183e-01 | 0.429 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 3.720183e-01 | 0.429 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.720183e-01 | 0.429 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.720183e-01 | 0.429 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.720183e-01 | 0.429 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.721155e-01 | 0.429 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.726217e-01 | 0.429 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.726217e-01 | 0.429 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.726217e-01 | 0.429 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.726217e-01 | 0.429 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.726217e-01 | 0.429 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.759858e-01 | 0.425 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.759858e-01 | 0.425 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.759858e-01 | 0.425 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.759858e-01 | 0.425 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.759858e-01 | 0.425 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.759858e-01 | 0.425 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.759858e-01 | 0.425 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 3.759858e-01 | 0.425 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.759858e-01 | 0.425 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.759858e-01 | 0.425 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 3.759858e-01 | 0.425 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.759858e-01 | 0.425 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.759858e-01 | 0.425 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.759858e-01 | 0.425 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.759858e-01 | 0.425 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 3.759858e-01 | 0.425 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.759858e-01 | 0.425 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.804496e-01 | 0.420 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.804496e-01 | 0.420 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.841577e-01 | 0.415 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.856134e-01 | 0.414 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.860024e-01 | 0.413 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.879222e-01 | 0.411 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.896782e-01 | 0.409 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.927843e-01 | 0.406 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 3.927843e-01 | 0.406 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.927843e-01 | 0.406 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.927843e-01 | 0.406 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.936257e-01 | 0.405 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.954978e-01 | 0.403 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.956833e-01 | 0.403 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.032358e-01 | 0.394 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.036305e-01 | 0.394 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.036305e-01 | 0.394 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.036305e-01 | 0.394 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 4.064036e-01 | 0.391 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.064036e-01 | 0.391 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.067580e-01 | 0.391 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.071889e-01 | 0.390 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.071889e-01 | 0.390 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.117165e-01 | 0.385 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.117165e-01 | 0.385 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.117165e-01 | 0.385 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.117165e-01 | 0.385 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 4.117165e-01 | 0.385 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.117165e-01 | 0.385 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.132328e-01 | 0.384 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.132328e-01 | 0.384 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.167482e-01 | 0.380 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.192199e-01 | 0.378 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.192199e-01 | 0.378 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.193023e-01 | 0.377 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.198335e-01 | 0.377 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.198335e-01 | 0.377 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.239597e-01 | 0.373 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.267140e-01 | 0.370 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.296558e-01 | 0.367 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.296558e-01 | 0.367 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 4.333324e-01 | 0.363 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.333324e-01 | 0.363 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.333324e-01 | 0.363 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.333324e-01 | 0.363 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.346713e-01 | 0.362 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.346713e-01 | 0.362 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.454034e-01 | 0.351 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.454034e-01 | 0.351 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.454034e-01 | 0.351 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.454034e-01 | 0.351 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 4.454034e-01 | 0.351 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.454034e-01 | 0.351 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 4.454034e-01 | 0.351 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.454034e-01 | 0.351 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.454034e-01 | 0.351 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 4.454034e-01 | 0.351 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.454034e-01 | 0.351 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.457647e-01 | 0.351 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.472100e-01 | 0.349 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.472100e-01 | 0.349 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.530559e-01 | 0.344 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 4.530559e-01 | 0.344 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.530559e-01 | 0.344 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.530559e-01 | 0.344 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.530559e-01 | 0.344 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.563061e-01 | 0.341 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.585974e-01 | 0.339 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.629337e-01 | 0.334 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.650918e-01 | 0.332 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.650918e-01 | 0.332 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.713272e-01 | 0.327 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.713272e-01 | 0.327 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.723805e-01 | 0.326 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.723805e-01 | 0.326 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.723805e-01 | 0.326 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.771632e-01 | 0.321 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.771632e-01 | 0.321 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.771632e-01 | 0.321 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.771632e-01 | 0.321 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.771632e-01 | 0.321 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.771632e-01 | 0.321 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.771632e-01 | 0.321 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.771632e-01 | 0.321 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.771632e-01 | 0.321 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.771632e-01 | 0.321 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.771632e-01 | 0.321 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.771632e-01 | 0.321 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.800301e-01 | 0.319 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.839442e-01 | 0.315 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.839442e-01 | 0.315 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.895673e-01 | 0.310 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.912873e-01 | 0.309 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.912873e-01 | 0.309 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.912873e-01 | 0.309 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.912873e-01 | 0.309 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.912873e-01 | 0.309 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.912873e-01 | 0.309 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.964391e-01 | 0.304 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.964391e-01 | 0.304 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.974756e-01 | 0.303 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.071060e-01 | 0.295 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.071060e-01 | 0.295 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.071060e-01 | 0.295 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.071060e-01 | 0.295 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.071060e-01 | 0.295 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.071060e-01 | 0.295 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.071060e-01 | 0.295 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.084257e-01 | 0.294 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.088032e-01 | 0.293 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.092960e-01 | 0.293 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.092960e-01 | 0.293 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.097608e-01 | 0.293 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.097608e-01 | 0.293 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.210285e-01 | 0.283 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.210285e-01 | 0.283 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.236006e-01 | 0.281 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.236006e-01 | 0.281 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.236006e-01 | 0.281 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.236006e-01 | 0.281 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.272511e-01 | 0.278 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.277885e-01 | 0.278 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.277885e-01 | 0.278 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.277885e-01 | 0.278 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.277885e-01 | 0.278 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.304823e-01 | 0.275 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.353356e-01 | 0.271 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.353356e-01 | 0.271 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.353356e-01 | 0.271 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.353356e-01 | 0.271 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 5.353356e-01 | 0.271 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.353356e-01 | 0.271 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.353356e-01 | 0.271 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.353356e-01 | 0.271 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 5.353356e-01 | 0.271 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 5.353356e-01 | 0.271 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 5.353356e-01 | 0.271 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 5.353356e-01 | 0.271 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.353356e-01 | 0.271 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.376731e-01 | 0.269 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.406701e-01 | 0.267 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.406701e-01 | 0.267 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.450331e-01 | 0.264 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.450331e-01 | 0.264 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.453610e-01 | 0.263 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.453610e-01 | 0.263 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.453610e-01 | 0.263 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.453610e-01 | 0.263 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.453610e-01 | 0.263 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.453610e-01 | 0.263 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.453610e-01 | 0.263 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.515050e-01 | 0.258 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.515050e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.515050e-01 | 0.258 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.515050e-01 | 0.258 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.515050e-01 | 0.258 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.515050e-01 | 0.258 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.567993e-01 | 0.254 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.567993e-01 | 0.254 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.567993e-01 | 0.254 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.567993e-01 | 0.254 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.597797e-01 | 0.252 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.615486e-01 | 0.251 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.615486e-01 | 0.251 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.616076e-01 | 0.251 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.619501e-01 | 0.250 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.619501e-01 | 0.250 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 5.619501e-01 | 0.250 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.619501e-01 | 0.250 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.619501e-01 | 0.250 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.619501e-01 | 0.250 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.619501e-01 | 0.250 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.624712e-01 | 0.250 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.624712e-01 | 0.250 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.624712e-01 | 0.250 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.624712e-01 | 0.250 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.645062e-01 | 0.248 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.660601e-01 | 0.247 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.684002e-01 | 0.245 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.703116e-01 | 0.244 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.750960e-01 | 0.240 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.784176e-01 | 0.238 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.784176e-01 | 0.238 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.791146e-01 | 0.237 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.791146e-01 | 0.237 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.791146e-01 | 0.237 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.791146e-01 | 0.237 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.798304e-01 | 0.237 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.798304e-01 | 0.237 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.870417e-01 | 0.231 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.870417e-01 | 0.231 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.870417e-01 | 0.231 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.870417e-01 | 0.231 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.870417e-01 | 0.231 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.870417e-01 | 0.231 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.870417e-01 | 0.231 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.870417e-01 | 0.231 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.870417e-01 | 0.231 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.870417e-01 | 0.231 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.910853e-01 | 0.228 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.914864e-01 | 0.228 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.920827e-01 | 0.228 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.937542e-01 | 0.226 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.952883e-01 | 0.225 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.952883e-01 | 0.225 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.952883e-01 | 0.225 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.952883e-01 | 0.225 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.952883e-01 | 0.225 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.952883e-01 | 0.225 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.021607e-01 | 0.220 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.042904e-01 | 0.219 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.058004e-01 | 0.218 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.106975e-01 | 0.214 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.106975e-01 | 0.214 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.106975e-01 | 0.214 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.106975e-01 | 0.214 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.106975e-01 | 0.214 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.106975e-01 | 0.214 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.106975e-01 | 0.214 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.106975e-01 | 0.214 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.106975e-01 | 0.214 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.106975e-01 | 0.214 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.106975e-01 | 0.214 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.106975e-01 | 0.214 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.109917e-01 | 0.214 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.109917e-01 | 0.214 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.109917e-01 | 0.214 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.109917e-01 | 0.214 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.130528e-01 | 0.213 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.130528e-01 | 0.213 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.143516e-01 | 0.212 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.168258e-01 | 0.210 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.168258e-01 | 0.210 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.168258e-01 | 0.210 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.168258e-01 | 0.210 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.237583e-01 | 0.205 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.262254e-01 | 0.203 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.262254e-01 | 0.203 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.290895e-01 | 0.201 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.329996e-01 | 0.199 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.329996e-01 | 0.199 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.329996e-01 | 0.199 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.329996e-01 | 0.199 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 6.329996e-01 | 0.199 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.329996e-01 | 0.199 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.329996e-01 | 0.199 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.409919e-01 | 0.193 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.409919e-01 | 0.193 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.444275e-01 | 0.191 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.444275e-01 | 0.191 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.445986e-01 | 0.191 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.521949e-01 | 0.186 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.527941e-01 | 0.185 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.540252e-01 | 0.184 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.540252e-01 | 0.184 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.540252e-01 | 0.184 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.540252e-01 | 0.184 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.540252e-01 | 0.184 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.540252e-01 | 0.184 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.540252e-01 | 0.184 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.540252e-01 | 0.184 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.540252e-01 | 0.184 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.540252e-01 | 0.184 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.540252e-01 | 0.184 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.547289e-01 | 0.184 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.691381e-01 | 0.174 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.691381e-01 | 0.174 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.691381e-01 | 0.174 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.738475e-01 | 0.171 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.738475e-01 | 0.171 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.738475e-01 | 0.171 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.738475e-01 | 0.171 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.738475e-01 | 0.171 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.738475e-01 | 0.171 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.738475e-01 | 0.171 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.738475e-01 | 0.171 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.744018e-01 | 0.171 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.752384e-01 | 0.171 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.759688e-01 | 0.170 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.759688e-01 | 0.170 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.822356e-01 | 0.166 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.822356e-01 | 0.166 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.825281e-01 | 0.166 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.839422e-01 | 0.165 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.839422e-01 | 0.165 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.862797e-01 | 0.163 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.862797e-01 | 0.163 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.866129e-01 | 0.163 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.924442e-01 | 0.160 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.925353e-01 | 0.160 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.925353e-01 | 0.160 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.925353e-01 | 0.160 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.925353e-01 | 0.160 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.925353e-01 | 0.160 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.925353e-01 | 0.160 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 6.925353e-01 | 0.160 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.925353e-01 | 0.160 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.943221e-01 | 0.158 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.954712e-01 | 0.158 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 6.954712e-01 | 0.158 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.954712e-01 | 0.158 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.954712e-01 | 0.158 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.954712e-01 | 0.158 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.994768e-01 | 0.155 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.012266e-01 | 0.154 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.024280e-01 | 0.153 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.026635e-01 | 0.153 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.060503e-01 | 0.151 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.088547e-01 | 0.149 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.101533e-01 | 0.149 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.101533e-01 | 0.149 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.101533e-01 | 0.149 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.101533e-01 | 0.149 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.101533e-01 | 0.149 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.101533e-01 | 0.149 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.101533e-01 | 0.149 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.172890e-01 | 0.144 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.172891e-01 | 0.144 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.200460e-01 | 0.143 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.200460e-01 | 0.143 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.200460e-01 | 0.143 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.201203e-01 | 0.143 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.252176e-01 | 0.140 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.267628e-01 | 0.139 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.267628e-01 | 0.139 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.267628e-01 | 0.139 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.267628e-01 | 0.139 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 7.267628e-01 | 0.139 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 7.267628e-01 | 0.139 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.267628e-01 | 0.139 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.267628e-01 | 0.139 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.366076e-01 | 0.133 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.402151e-01 | 0.131 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.424215e-01 | 0.129 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.424215e-01 | 0.129 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.424215e-01 | 0.129 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.424215e-01 | 0.129 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.424215e-01 | 0.129 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.424215e-01 | 0.129 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.424215e-01 | 0.129 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.424215e-01 | 0.129 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.424215e-01 | 0.129 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.424215e-01 | 0.129 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.424215e-01 | 0.129 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.429276e-01 | 0.129 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.429276e-01 | 0.129 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 7.451799e-01 | 0.128 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.451799e-01 | 0.128 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.458679e-01 | 0.127 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.475468e-01 | 0.126 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.537558e-01 | 0.123 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.571837e-01 | 0.121 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.571837e-01 | 0.121 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.571837e-01 | 0.121 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.571837e-01 | 0.121 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.636064e-01 | 0.117 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.641882e-01 | 0.117 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.641882e-01 | 0.117 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.643740e-01 | 0.117 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.684915e-01 | 0.114 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.711006e-01 | 0.113 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.711006e-01 | 0.113 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.711006e-01 | 0.113 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.711006e-01 | 0.113 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.711006e-01 | 0.113 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.720917e-01 | 0.112 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.721176e-01 | 0.112 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.738041e-01 | 0.111 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.742346e-01 | 0.111 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.742346e-01 | 0.111 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.742346e-01 | 0.111 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.803261e-01 | 0.108 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.803261e-01 | 0.108 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.808446e-01 | 0.107 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.828871e-01 | 0.106 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.839050e-01 | 0.106 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.839050e-01 | 0.106 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.839050e-01 | 0.106 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.842208e-01 | 0.106 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.842208e-01 | 0.106 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.842208e-01 | 0.106 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.842208e-01 | 0.106 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.842208e-01 | 0.106 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.842208e-01 | 0.106 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.842208e-01 | 0.106 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.842208e-01 | 0.106 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.883265e-01 | 0.103 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.904876e-01 | 0.102 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.932094e-01 | 0.101 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.965896e-01 | 0.099 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.965896e-01 | 0.099 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.965896e-01 | 0.099 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.007230e-01 | 0.097 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.035875e-01 | 0.095 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.067031e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.082501e-01 | 0.092 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.082501e-01 | 0.092 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.082501e-01 | 0.092 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.082501e-01 | 0.092 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.082501e-01 | 0.092 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.082501e-01 | 0.092 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.100630e-01 | 0.091 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.107611e-01 | 0.091 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.107611e-01 | 0.091 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.129112e-01 | 0.090 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.129112e-01 | 0.090 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.163632e-01 | 0.088 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.176262e-01 | 0.087 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.190287e-01 | 0.087 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.190287e-01 | 0.087 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.190287e-01 | 0.087 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.192429e-01 | 0.087 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.192429e-01 | 0.087 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.192429e-01 | 0.087 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.192429e-01 | 0.087 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.192429e-01 | 0.087 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.214683e-01 | 0.085 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.247034e-01 | 0.084 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.269711e-01 | 0.083 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.292074e-01 | 0.081 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.293307e-01 | 0.081 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.296061e-01 | 0.081 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.296061e-01 | 0.081 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.296061e-01 | 0.081 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.296061e-01 | 0.081 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.296061e-01 | 0.081 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 8.296061e-01 | 0.081 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.296061e-01 | 0.081 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.296061e-01 | 0.081 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.344885e-01 | 0.079 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.366869e-01 | 0.077 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.376899e-01 | 0.077 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.393757e-01 | 0.076 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.393757e-01 | 0.076 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.393757e-01 | 0.076 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.393757e-01 | 0.076 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.414215e-01 | 0.075 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.481459e-01 | 0.072 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.485858e-01 | 0.071 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.485858e-01 | 0.071 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.485858e-01 | 0.071 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.485858e-01 | 0.071 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.485858e-01 | 0.071 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.489475e-01 | 0.071 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.489475e-01 | 0.071 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.506387e-01 | 0.070 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.506387e-01 | 0.070 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.556889e-01 | 0.068 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.572683e-01 | 0.067 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.572683e-01 | 0.067 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.572683e-01 | 0.067 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.572683e-01 | 0.067 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.572683e-01 | 0.067 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.572683e-01 | 0.067 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.572683e-01 | 0.067 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.603071e-01 | 0.065 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.607915e-01 | 0.065 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.611861e-01 | 0.065 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.611861e-01 | 0.065 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.621546e-01 | 0.064 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.654534e-01 | 0.063 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.654534e-01 | 0.063 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.665729e-01 | 0.062 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.675376e-01 | 0.062 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.705903e-01 | 0.060 | 1 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.731695e-01 | 0.059 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.731695e-01 | 0.059 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.731695e-01 | 0.059 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.731695e-01 | 0.059 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.742959e-01 | 0.058 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.742959e-01 | 0.058 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.749123e-01 | 0.058 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.804436e-01 | 0.055 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.804436e-01 | 0.055 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.804436e-01 | 0.055 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.804436e-01 | 0.055 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.830241e-01 | 0.054 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.830241e-01 | 0.054 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.854449e-01 | 0.053 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.864093e-01 | 0.052 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.873010e-01 | 0.052 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.873010e-01 | 0.052 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.873010e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.873010e-01 | 0.052 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.873010e-01 | 0.052 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.873010e-01 | 0.052 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.897120e-01 | 0.051 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.906694e-01 | 0.050 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.906694e-01 | 0.050 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.929336e-01 | 0.049 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.937654e-01 | 0.049 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.956719e-01 | 0.048 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.964340e-01 | 0.047 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.998593e-01 | 0.046 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.998593e-01 | 0.046 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.021965e-01 | 0.045 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.034123e-01 | 0.044 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.050438e-01 | 0.043 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.056041e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.056041e-01 | 0.043 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.056041e-01 | 0.043 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.066596e-01 | 0.043 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.094291e-01 | 0.041 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.094291e-01 | 0.041 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.110196e-01 | 0.040 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.110196e-01 | 0.040 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.110196e-01 | 0.040 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.110196e-01 | 0.040 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.110196e-01 | 0.040 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.110196e-01 | 0.040 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.110196e-01 | 0.040 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.110196e-01 | 0.040 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.119927e-01 | 0.040 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.136241e-01 | 0.039 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.136241e-01 | 0.039 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.161247e-01 | 0.038 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.161247e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.161247e-01 | 0.038 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.161247e-01 | 0.038 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.176363e-01 | 0.037 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.201859e-01 | 0.036 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.209373e-01 | 0.036 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.209373e-01 | 0.036 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.209373e-01 | 0.036 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.209373e-01 | 0.036 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.237076e-01 | 0.034 | 1 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.254739e-01 | 0.034 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.254739e-01 | 0.034 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.254739e-01 | 0.034 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.254739e-01 | 0.034 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.254739e-01 | 0.034 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.278234e-01 | 0.033 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.280600e-01 | 0.032 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.297505e-01 | 0.032 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.297505e-01 | 0.032 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.297505e-01 | 0.032 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.297505e-01 | 0.032 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.319963e-01 | 0.031 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.337820e-01 | 0.030 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.337820e-01 | 0.030 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.337820e-01 | 0.030 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.349571e-01 | 0.029 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.351973e-01 | 0.029 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.366209e-01 | 0.028 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.375823e-01 | 0.028 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.375823e-01 | 0.028 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.375823e-01 | 0.028 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.375823e-01 | 0.028 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.375823e-01 | 0.028 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.375823e-01 | 0.028 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.375823e-01 | 0.028 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.400850e-01 | 0.027 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.400850e-01 | 0.027 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.411647e-01 | 0.026 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.411647e-01 | 0.026 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.440929e-01 | 0.025 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.445418e-01 | 0.025 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.463959e-01 | 0.024 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.466274e-01 | 0.024 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.466274e-01 | 0.024 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.466274e-01 | 0.024 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.477252e-01 | 0.023 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.487114e-01 | 0.023 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.491694e-01 | 0.023 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.491694e-01 | 0.023 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.494026e-01 | 0.023 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.495275e-01 | 0.022 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.495275e-01 | 0.022 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.501852e-01 | 0.022 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.507260e-01 | 0.022 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.507260e-01 | 0.022 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.508851e-01 | 0.022 | 1 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.515956e-01 | 0.022 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.535547e-01 | 0.021 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.546670e-01 | 0.020 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.561203e-01 | 0.019 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.562212e-01 | 0.019 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.562212e-01 | 0.019 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.562212e-01 | 0.019 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.562212e-01 | 0.019 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.562212e-01 | 0.019 | 1 | 1 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.562212e-01 | 0.019 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.566485e-01 | 0.019 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.587348e-01 | 0.018 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.587348e-01 | 0.018 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.587348e-01 | 0.018 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.602386e-01 | 0.018 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.611042e-01 | 0.017 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.611042e-01 | 0.017 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.611042e-01 | 0.017 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.611042e-01 | 0.017 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.621561e-01 | 0.017 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.622218e-01 | 0.017 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.633377e-01 | 0.016 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.633377e-01 | 0.016 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.654431e-01 | 0.015 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.657282e-01 | 0.015 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.669201e-01 | 0.015 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.692984e-01 | 0.014 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.692984e-01 | 0.014 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.692984e-01 | 0.014 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.696741e-01 | 0.013 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.696741e-01 | 0.013 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.702310e-01 | 0.013 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.710618e-01 | 0.013 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.710618e-01 | 0.013 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.710632e-01 | 0.013 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.719242e-01 | 0.012 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.727240e-01 | 0.012 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.727240e-01 | 0.012 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.727865e-01 | 0.012 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.742908e-01 | 0.011 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.747117e-01 | 0.011 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.757677e-01 | 0.011 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.771598e-01 | 0.010 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.771598e-01 | 0.010 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.771598e-01 | 0.010 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.781616e-01 | 0.010 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.802609e-01 | 0.009 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.802932e-01 | 0.009 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.808749e-01 | 0.008 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.810771e-01 | 0.008 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.819739e-01 | 0.008 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.823033e-01 | 0.008 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.826411e-01 | 0.008 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.826411e-01 | 0.008 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.826411e-01 | 0.008 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.830099e-01 | 0.007 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.830475e-01 | 0.007 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.833631e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.839863e-01 | 0.007 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.839863e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.842997e-01 | 0.007 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.847226e-01 | 0.007 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.849067e-01 | 0.007 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.857742e-01 | 0.006 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.865919e-01 | 0.006 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.868647e-01 | 0.006 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.876751e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.878568e-01 | 0.005 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.878568e-01 | 0.005 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.880892e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.880892e-01 | 0.005 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.881448e-01 | 0.005 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.893030e-01 | 0.005 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.900278e-01 | 0.004 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.902003e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.906012e-01 | 0.004 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.906012e-01 | 0.004 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.911417e-01 | 0.004 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.917366e-01 | 0.004 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.924082e-01 | 0.003 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.925839e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.937915e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.937915e-01 | 0.003 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.941486e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.942571e-01 | 0.003 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.945492e-01 | 0.002 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.948026e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.953410e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.953835e-01 | 0.002 | 1 | 1 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.958049e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.958049e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.958049e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.961153e-01 | 0.002 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.961356e-01 | 0.002 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.963580e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.964739e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.966406e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.971270e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.974919e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.976164e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.977337e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.983841e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.984336e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.986552e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.989690e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.990245e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.992701e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993483e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.995386e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.996236e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.996610e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.997327e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.998015e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998181e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.998339e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998420e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.998905e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998922e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999310e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999359e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999686e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999697e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999712e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999907e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999940e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999941e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999943e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999984e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999985e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999994e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999996e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999997e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999998e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.000000e+00 | 0.000 | 1 | 1 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 1.662499e-10 | 9.779 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.411798e-10 | 9.850 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.108496e-09 | 8.386 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.039464e-08 | 7.983 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.295827e-07 | 6.639 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.176746e-07 | 6.498 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.504384e-07 | 6.346 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.078842e-06 | 5.967 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.018512e-06 | 5.992 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.227216e-06 | 5.911 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.392989e-06 | 5.856 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.290268e-06 | 5.640 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.452839e-06 | 5.610 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.229931e-06 | 5.374 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.220302e-06 | 5.282 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.370711e-05 | 4.863 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.969104e-05 | 4.706 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.937550e-05 | 4.713 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.436550e-05 | 4.613 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.757263e-05 | 4.560 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.742260e-05 | 4.427 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.124910e-05 | 4.385 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.003385e-05 | 4.398 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.795399e-05 | 4.237 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.795399e-05 | 4.237 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.766322e-05 | 4.170 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.801257e-05 | 4.167 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.116408e-05 | 4.148 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.033349e-04 | 3.986 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.033349e-04 | 3.986 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.102543e-04 | 3.958 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.055476e-04 | 3.977 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.310223e-04 | 3.883 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.331051e-04 | 3.876 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.487472e-04 | 3.828 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.499340e-04 | 3.824 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.678624e-04 | 3.775 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.813026e-04 | 3.742 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.937992e-04 | 3.713 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.048246e-04 | 3.689 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.066360e-04 | 3.685 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.100516e-04 | 3.678 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.444341e-04 | 3.612 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.575195e-04 | 3.589 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.735124e-04 | 3.563 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.855558e-04 | 3.544 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.208782e-04 | 3.494 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.231816e-04 | 3.491 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.408956e-04 | 3.467 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.703853e-04 | 3.431 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.115692e-04 | 3.386 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.248638e-04 | 3.372 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.934432e-04 | 3.307 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.934432e-04 | 3.307 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.914043e-04 | 3.228 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.914043e-04 | 3.228 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.998823e-04 | 3.222 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.120395e-04 | 3.213 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.908357e-04 | 3.161 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.992102e-04 | 3.097 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.002657e-04 | 3.097 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.346519e-04 | 3.078 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.169076e-04 | 3.038 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.691195e-04 | 3.014 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.052817e-03 | 2.978 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.086797e-03 | 2.964 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.114257e-03 | 2.953 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.076801e-03 | 2.968 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.175927e-03 | 2.930 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.228084e-03 | 2.911 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.204936e-03 | 2.919 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.229373e-03 | 2.910 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.233815e-03 | 2.909 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.244520e-03 | 2.905 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.318119e-03 | 2.880 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.281745e-03 | 2.892 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.340097e-03 | 2.873 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.424285e-03 | 2.846 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.482050e-03 | 2.829 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.421173e-03 | 2.847 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.607418e-03 | 2.794 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.607418e-03 | 2.794 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.946456e-03 | 2.711 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.942602e-03 | 2.712 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.959908e-03 | 2.708 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.946456e-03 | 2.711 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.942602e-03 | 2.712 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.881990e-03 | 2.725 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.999099e-03 | 2.699 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.999099e-03 | 2.699 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.120481e-03 | 2.674 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.192975e-03 | 2.659 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.283727e-03 | 2.641 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.322353e-03 | 2.634 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.352237e-03 | 2.629 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.617605e-03 | 2.582 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.617605e-03 | 2.582 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.482859e-03 | 2.605 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.575073e-03 | 2.589 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.648595e-03 | 2.577 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.052154e-03 | 2.515 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.246854e-03 | 2.489 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.432051e-03 | 2.464 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.271901e-03 | 2.485 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.453294e-03 | 2.462 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.620876e-03 | 2.441 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.908100e-03 | 2.408 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.908100e-03 | 2.408 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.029122e-03 | 2.395 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.898598e-03 | 2.409 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.140584e-03 | 2.383 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.430197e-03 | 2.354 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.207836e-03 | 2.376 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.367151e-03 | 2.360 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.277387e-03 | 2.369 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.717811e-03 | 2.326 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.127578e-03 | 2.290 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.127578e-03 | 2.290 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.127578e-03 | 2.290 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.127578e-03 | 2.290 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.012654e-03 | 2.300 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.802739e-03 | 2.319 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.802739e-03 | 2.319 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.802739e-03 | 2.319 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.456265e-03 | 2.263 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.456265e-03 | 2.263 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.103777e-03 | 2.292 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.695003e-03 | 2.245 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.740482e-03 | 2.241 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.880197e-03 | 2.231 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.126533e-03 | 2.213 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.159052e-03 | 2.210 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.718945e-03 | 2.173 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.404461e-03 | 2.194 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.646611e-03 | 2.177 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.425449e-03 | 2.192 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.789337e-03 | 2.168 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.789337e-03 | 2.168 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.789337e-03 | 2.168 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.461009e-03 | 2.127 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.405483e-03 | 2.130 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.405483e-03 | 2.130 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.405483e-03 | 2.130 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.405483e-03 | 2.130 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.487047e-03 | 2.126 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.461009e-03 | 2.127 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.461009e-03 | 2.127 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.328571e-03 | 2.135 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.159340e-03 | 2.145 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.566565e-03 | 2.121 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.740098e-03 | 2.111 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.781053e-03 | 2.109 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.781354e-03 | 2.109 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.831315e-03 | 2.106 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.837342e-03 | 2.106 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.072542e-03 | 2.093 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.211149e-03 | 2.086 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.337183e-03 | 2.079 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.360711e-03 | 2.078 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.560019e-03 | 2.068 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.845565e-03 | 2.053 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.277319e-03 | 2.033 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.013301e-02 | 1.994 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.217386e-03 | 2.035 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.356420e-03 | 2.029 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.022762e-02 | 1.990 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.023234e-02 | 1.990 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.072118e-02 | 1.970 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.075819e-02 | 1.968 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.080548e-02 | 1.966 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.080548e-02 | 1.966 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.080548e-02 | 1.966 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.097435e-02 | 1.960 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.207511e-02 | 1.918 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.207511e-02 | 1.918 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.163946e-02 | 1.934 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.135717e-02 | 1.945 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.115368e-02 | 1.953 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.192141e-02 | 1.924 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.163946e-02 | 1.934 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.165605e-02 | 1.933 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.165605e-02 | 1.933 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.207511e-02 | 1.918 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.207511e-02 | 1.918 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.214836e-02 | 1.915 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.222053e-02 | 1.913 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.223489e-02 | 1.912 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.251861e-02 | 1.902 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.252722e-02 | 1.902 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.265065e-02 | 1.898 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.290846e-02 | 1.889 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.293005e-02 | 1.888 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.326110e-02 | 1.877 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.333450e-02 | 1.875 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.419860e-02 | 1.848 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.419860e-02 | 1.848 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.384609e-02 | 1.859 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.482390e-02 | 1.829 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.482390e-02 | 1.829 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.431495e-02 | 1.844 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.419860e-02 | 1.848 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.445307e-02 | 1.840 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.514378e-02 | 1.820 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.472881e-02 | 1.832 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.407192e-02 | 1.852 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.529090e-02 | 1.816 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.539469e-02 | 1.813 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.565227e-02 | 1.805 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.586991e-02 | 1.799 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.643448e-02 | 1.784 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.714437e-02 | 1.766 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.717903e-02 | 1.765 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.718343e-02 | 1.765 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.718343e-02 | 1.765 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.724134e-02 | 1.763 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.784994e-02 | 1.748 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.805842e-02 | 1.743 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.996682e-02 | 1.700 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.996682e-02 | 1.700 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.970051e-02 | 1.706 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.085728e-02 | 1.681 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.085728e-02 | 1.681 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.085728e-02 | 1.681 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.085728e-02 | 1.681 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.085728e-02 | 1.681 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.873851e-02 | 1.727 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.838338e-02 | 1.736 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.838338e-02 | 1.736 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.087691e-02 | 1.680 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.087691e-02 | 1.680 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.989068e-02 | 1.701 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.863209e-02 | 1.730 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.863209e-02 | 1.730 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.873851e-02 | 1.727 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.833473e-02 | 1.737 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.087691e-02 | 1.680 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.121787e-02 | 1.673 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.137233e-02 | 1.670 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.137233e-02 | 1.670 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.210546e-02 | 1.656 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.222121e-02 | 1.653 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.222121e-02 | 1.653 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.270798e-02 | 1.644 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.324798e-02 | 1.634 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.324798e-02 | 1.634 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.324798e-02 | 1.634 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.329090e-02 | 1.633 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.329090e-02 | 1.633 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.329090e-02 | 1.633 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.492806e-02 | 1.603 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.492806e-02 | 1.603 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.492806e-02 | 1.603 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.769535e-02 | 1.558 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.769535e-02 | 1.558 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.772870e-02 | 1.557 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.772870e-02 | 1.557 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.662043e-02 | 1.575 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.537147e-02 | 1.596 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.477699e-02 | 1.606 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.477699e-02 | 1.606 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.477699e-02 | 1.606 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.477699e-02 | 1.606 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.477699e-02 | 1.606 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.825228e-02 | 1.549 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.747414e-02 | 1.561 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.644036e-02 | 1.578 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.859203e-02 | 1.544 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.859203e-02 | 1.544 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.532273e-02 | 1.596 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.772870e-02 | 1.557 | 1 | 1 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.858355e-02 | 1.544 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.620622e-02 | 1.582 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.769535e-02 | 1.558 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.825228e-02 | 1.549 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.887907e-02 | 1.539 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.887907e-02 | 1.539 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.905520e-02 | 1.537 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.915657e-02 | 1.535 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.915657e-02 | 1.535 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.915657e-02 | 1.535 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.915657e-02 | 1.535 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.990564e-02 | 1.524 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.042787e-02 | 1.517 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.062968e-02 | 1.514 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.116906e-02 | 1.506 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.162166e-02 | 1.500 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.248555e-02 | 1.488 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.248555e-02 | 1.488 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.248555e-02 | 1.488 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.277889e-02 | 1.484 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.277889e-02 | 1.484 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.278424e-02 | 1.484 | 1 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.318708e-02 | 1.479 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.365297e-02 | 1.473 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.383015e-02 | 1.471 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.387951e-02 | 1.470 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.414899e-02 | 1.467 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.469813e-02 | 1.460 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.508191e-02 | 1.455 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.580813e-02 | 1.446 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.580813e-02 | 1.446 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.581836e-02 | 1.446 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.591265e-02 | 1.445 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.591265e-02 | 1.445 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.106691e-02 | 1.387 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.726296e-02 | 1.429 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.726296e-02 | 1.429 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.726296e-02 | 1.429 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.357915e-02 | 1.361 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.068914e-02 | 1.391 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.254117e-02 | 1.371 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.041111e-02 | 1.393 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.041111e-02 | 1.393 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.726296e-02 | 1.429 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.019577e-02 | 1.396 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.996688e-02 | 1.398 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.041111e-02 | 1.393 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.634191e-02 | 1.440 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.277443e-02 | 1.369 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.359943e-02 | 1.361 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.294951e-02 | 1.367 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.791395e-02 | 1.421 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.949736e-02 | 1.403 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.431651e-02 | 1.353 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.466896e-02 | 1.350 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.468159e-02 | 1.350 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.468159e-02 | 1.350 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.500409e-02 | 1.347 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.559582e-02 | 1.341 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.559582e-02 | 1.341 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.559582e-02 | 1.341 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.574623e-02 | 1.340 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.574623e-02 | 1.340 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.590236e-02 | 1.338 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.590236e-02 | 1.338 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.590236e-02 | 1.338 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.590236e-02 | 1.338 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.590236e-02 | 1.338 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.590236e-02 | 1.338 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.625846e-02 | 1.335 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.724409e-02 | 1.326 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.812821e-02 | 1.318 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.871375e-02 | 1.312 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.871375e-02 | 1.312 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.871375e-02 | 1.312 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.977410e-02 | 1.303 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.985756e-02 | 1.302 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.985958e-02 | 1.302 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.005623e-02 | 1.301 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 5.434844e-02 | 1.265 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.434844e-02 | 1.265 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.434844e-02 | 1.265 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.553369e-02 | 1.255 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.741059e-02 | 1.241 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.741059e-02 | 1.241 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.741059e-02 | 1.241 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.680810e-02 | 1.246 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.680810e-02 | 1.246 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.492028e-02 | 1.260 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.237328e-02 | 1.281 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.227110e-02 | 1.206 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.227110e-02 | 1.206 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.835591e-02 | 1.234 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.835591e-02 | 1.234 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.835591e-02 | 1.234 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.080997e-02 | 1.216 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.247115e-02 | 1.280 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.125364e-02 | 1.290 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.910791e-02 | 1.228 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.910791e-02 | 1.228 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.910791e-02 | 1.228 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.553369e-02 | 1.255 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.227110e-02 | 1.206 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.421243e-02 | 1.266 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.158117e-02 | 1.211 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.553369e-02 | 1.255 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.577621e-02 | 1.254 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.793078e-02 | 1.237 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.081977e-02 | 1.216 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.064361e-02 | 1.217 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.553369e-02 | 1.255 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.158117e-02 | 1.211 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.421243e-02 | 1.266 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.300614e-02 | 1.201 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.306061e-02 | 1.200 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.060125e-02 | 1.296 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.345235e-02 | 1.198 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.345235e-02 | 1.198 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.503824e-02 | 1.187 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.607119e-02 | 1.180 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.612901e-02 | 1.180 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.612901e-02 | 1.180 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.612901e-02 | 1.180 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.612901e-02 | 1.180 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.686498e-02 | 1.175 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.686498e-02 | 1.175 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.686498e-02 | 1.175 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.686498e-02 | 1.175 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.805241e-02 | 1.167 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.865392e-02 | 1.163 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.956848e-02 | 1.158 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.958768e-02 | 1.157 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.989393e-02 | 1.156 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.989393e-02 | 1.156 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.989393e-02 | 1.156 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.161789e-02 | 1.145 | 1 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.210121e-02 | 1.142 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.210121e-02 | 1.142 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.210121e-02 | 1.142 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.210121e-02 | 1.142 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.258164e-02 | 1.139 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.258164e-02 | 1.139 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.259215e-02 | 1.139 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.259215e-02 | 1.139 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.259215e-02 | 1.139 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.259215e-02 | 1.139 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.259215e-02 | 1.139 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.259215e-02 | 1.139 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.328386e-02 | 1.135 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.328386e-02 | 1.135 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.328386e-02 | 1.135 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.328386e-02 | 1.135 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.547221e-02 | 1.122 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.745129e-02 | 1.111 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.797156e-02 | 1.108 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.797156e-02 | 1.108 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.839843e-02 | 1.106 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.839843e-02 | 1.106 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.841341e-02 | 1.106 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.865181e-02 | 1.104 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.877914e-02 | 1.104 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.890751e-02 | 1.103 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 9.263858e-02 | 1.033 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.263858e-02 | 1.033 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 8.324927e-02 | 1.080 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 8.324927e-02 | 1.080 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 8.324927e-02 | 1.080 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 8.324927e-02 | 1.080 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.215515e-02 | 1.035 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.215515e-02 | 1.035 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.215515e-02 | 1.035 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.215515e-02 | 1.035 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 9.216300e-02 | 1.035 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 9.216300e-02 | 1.035 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 9.216300e-02 | 1.035 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.874708e-02 | 1.052 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.874708e-02 | 1.052 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.073028e-01 | 0.969 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.073028e-01 | 0.969 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.073028e-01 | 0.969 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.073028e-01 | 0.969 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.073028e-01 | 0.969 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.073028e-01 | 0.969 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.073028e-01 | 0.969 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.249284e-02 | 1.034 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.869521e-02 | 1.006 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.869521e-02 | 1.006 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.049295e-02 | 1.043 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.049295e-02 | 1.043 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.031936e-01 | 0.986 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.031936e-01 | 0.986 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.031936e-01 | 0.986 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.427099e-02 | 1.026 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.518728e-02 | 1.070 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.518728e-02 | 1.070 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.482130e-02 | 1.071 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.998046e-02 | 1.000 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.516437e-02 | 1.022 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.620735e-02 | 1.064 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.068757e-01 | 0.971 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.031936e-01 | 0.986 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.552467e-02 | 1.068 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.381046e-02 | 1.077 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.381046e-02 | 1.077 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.542924e-02 | 1.068 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.299336e-02 | 1.081 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.215515e-02 | 1.035 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.987343e-02 | 1.001 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.869521e-02 | 1.006 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.906947e-02 | 1.004 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 8.324927e-02 | 1.080 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.042380e-02 | 1.044 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.310674e-02 | 1.031 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.987343e-02 | 1.001 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.906947e-02 | 1.004 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.671296e-02 | 1.062 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.869521e-02 | 1.006 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 9.215515e-02 | 1.035 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.463337e-02 | 1.072 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.013826e-01 | 0.994 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 8.324927e-02 | 1.080 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.239135e-02 | 1.034 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.987343e-02 | 1.001 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.987343e-02 | 1.001 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.031936e-01 | 0.986 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.103118e-02 | 1.091 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.102223e-01 | 0.958 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.102223e-01 | 0.958 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.111708e-01 | 0.954 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.116140e-01 | 0.952 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.117846e-01 | 0.952 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.117846e-01 | 0.952 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.122964e-01 | 0.950 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.130832e-01 | 0.947 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.130832e-01 | 0.947 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.130832e-01 | 0.947 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.141654e-01 | 0.942 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.141654e-01 | 0.942 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.141654e-01 | 0.942 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.141654e-01 | 0.942 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.168713e-01 | 0.932 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.173295e-01 | 0.931 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 1.173295e-01 | 0.931 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.173309e-01 | 0.931 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.173309e-01 | 0.931 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.173309e-01 | 0.931 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.173309e-01 | 0.931 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.173309e-01 | 0.931 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.173309e-01 | 0.931 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.173309e-01 | 0.931 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.189449e-01 | 0.925 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.189449e-01 | 0.925 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.189449e-01 | 0.925 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.189449e-01 | 0.925 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.189449e-01 | 0.925 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.189449e-01 | 0.925 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.189449e-01 | 0.925 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.194459e-01 | 0.923 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.199029e-01 | 0.921 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.199029e-01 | 0.921 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.208597e-01 | 0.918 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.216476e-01 | 0.915 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.220846e-01 | 0.913 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.240607e-01 | 0.906 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.276873e-01 | 0.894 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.276873e-01 | 0.894 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.276873e-01 | 0.894 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.557888e-01 | 0.807 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.557888e-01 | 0.807 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.557888e-01 | 0.807 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.557888e-01 | 0.807 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.557888e-01 | 0.807 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.557888e-01 | 0.807 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.557888e-01 | 0.807 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.557888e-01 | 0.807 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.557888e-01 | 0.807 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.479708e-01 | 0.830 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.479708e-01 | 0.830 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.556449e-01 | 0.808 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.556449e-01 | 0.808 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.556449e-01 | 0.808 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.486612e-01 | 0.828 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.486612e-01 | 0.828 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.486612e-01 | 0.828 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.486612e-01 | 0.828 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.486612e-01 | 0.828 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.384217e-01 | 0.859 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.384217e-01 | 0.859 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.384217e-01 | 0.859 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.384217e-01 | 0.859 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.384217e-01 | 0.859 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.384217e-01 | 0.859 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.384217e-01 | 0.859 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.808822e-01 | 0.743 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.808822e-01 | 0.743 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.808822e-01 | 0.743 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.808822e-01 | 0.743 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.362552e-01 | 0.866 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 1.362552e-01 | 0.866 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.734658e-01 | 0.761 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.417121e-01 | 0.849 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.605334e-01 | 0.794 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.605334e-01 | 0.794 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.451056e-01 | 0.838 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.451056e-01 | 0.838 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.315071e-01 | 0.881 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.333201e-01 | 0.875 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.333201e-01 | 0.875 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.470734e-01 | 0.832 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.342979e-01 | 0.872 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.480249e-01 | 0.830 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.635337e-01 | 0.786 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.482348e-01 | 0.829 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.635313e-01 | 0.786 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.808441e-01 | 0.743 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.603761e-01 | 0.795 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.361450e-01 | 0.866 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.793849e-01 | 0.746 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.745241e-01 | 0.758 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.613876e-01 | 0.792 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.613876e-01 | 0.792 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.731275e-01 | 0.762 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.605334e-01 | 0.794 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.605334e-01 | 0.794 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.808441e-01 | 0.743 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.804514e-01 | 0.744 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.675221e-01 | 0.776 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.474461e-01 | 0.831 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.782619e-01 | 0.749 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.782619e-01 | 0.749 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.346466e-01 | 0.871 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.527035e-01 | 0.816 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.635313e-01 | 0.786 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.923672e-01 | 0.716 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.675221e-01 | 0.776 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.315071e-01 | 0.881 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.432553e-01 | 0.844 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.808822e-01 | 0.743 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.808822e-01 | 0.743 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.470734e-01 | 0.832 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.345144e-01 | 0.871 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.780508e-01 | 0.749 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.505197e-01 | 0.822 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.332171e-01 | 0.875 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.635337e-01 | 0.786 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.359726e-01 | 0.867 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.647207e-01 | 0.783 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.482348e-01 | 0.829 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.431942e-01 | 0.844 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.431942e-01 | 0.844 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.368454e-01 | 0.864 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.368454e-01 | 0.864 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.384217e-01 | 0.859 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.384217e-01 | 0.859 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.605334e-01 | 0.794 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.923672e-01 | 0.716 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.480249e-01 | 0.830 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.886898e-01 | 0.724 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.457612e-01 | 0.836 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.556449e-01 | 0.808 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.333201e-01 | 0.875 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.635337e-01 | 0.786 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.855924e-01 | 0.731 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.855924e-01 | 0.731 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.855924e-01 | 0.731 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.855924e-01 | 0.731 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.302576e-01 | 0.885 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.845748e-01 | 0.734 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.579222e-01 | 0.802 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.451056e-01 | 0.838 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.315071e-01 | 0.881 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.850608e-01 | 0.733 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.384217e-01 | 0.859 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.808441e-01 | 0.743 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.577340e-01 | 0.802 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.618071e-01 | 0.791 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.618071e-01 | 0.791 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.798041e-01 | 0.745 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.296591e-01 | 0.887 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.588354e-01 | 0.799 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.479708e-01 | 0.830 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.635337e-01 | 0.786 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.811683e-01 | 0.742 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.798041e-01 | 0.745 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.565701e-01 | 0.805 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.315071e-01 | 0.881 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.447534e-01 | 0.839 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.855924e-01 | 0.731 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.470734e-01 | 0.832 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.550047e-01 | 0.810 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.635313e-01 | 0.786 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.734658e-01 | 0.761 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.497881e-01 | 0.825 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.808822e-01 | 0.743 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.836421e-01 | 0.736 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.301044e-01 | 0.886 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.333201e-01 | 0.875 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.480249e-01 | 0.830 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.886898e-01 | 0.724 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.482348e-01 | 0.829 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.482348e-01 | 0.829 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.928179e-01 | 0.715 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.928179e-01 | 0.715 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.928179e-01 | 0.715 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.968022e-01 | 0.706 | 1 | 1 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.968022e-01 | 0.706 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.968022e-01 | 0.706 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.968022e-01 | 0.706 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.971995e-01 | 0.705 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.971995e-01 | 0.705 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.971995e-01 | 0.705 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.971995e-01 | 0.705 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.971995e-01 | 0.705 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.971995e-01 | 0.705 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.971995e-01 | 0.705 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.971995e-01 | 0.705 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.971995e-01 | 0.705 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.985598e-01 | 0.702 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.005694e-01 | 0.698 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.009581e-01 | 0.697 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.009581e-01 | 0.697 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.035679e-01 | 0.691 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.055647e-01 | 0.687 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.057905e-01 | 0.687 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.057905e-01 | 0.687 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 2.080885e-01 | 0.682 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 2.080885e-01 | 0.682 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.101244e-01 | 0.678 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.109453e-01 | 0.676 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.144793e-01 | 0.669 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.144793e-01 | 0.669 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.144793e-01 | 0.669 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.145428e-01 | 0.668 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.151527e-01 | 0.667 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.151527e-01 | 0.667 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.151527e-01 | 0.667 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.151527e-01 | 0.667 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.151527e-01 | 0.667 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.151527e-01 | 0.667 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.178043e-01 | 0.662 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.187398e-01 | 0.660 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.190368e-01 | 0.659 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 2.873150e-01 | 0.542 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.873150e-01 | 0.542 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.873150e-01 | 0.542 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.873150e-01 | 0.542 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.873150e-01 | 0.542 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.873150e-01 | 0.542 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.873150e-01 | 0.542 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.873150e-01 | 0.542 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.873150e-01 | 0.542 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.873150e-01 | 0.542 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.701589e-01 | 0.568 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.701589e-01 | 0.568 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.701589e-01 | 0.568 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.701589e-01 | 0.568 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.701589e-01 | 0.568 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.983560e-01 | 0.400 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.983560e-01 | 0.400 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.983560e-01 | 0.400 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 3.983560e-01 | 0.400 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.983560e-01 | 0.400 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.983560e-01 | 0.400 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.983560e-01 | 0.400 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.983560e-01 | 0.400 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.983560e-01 | 0.400 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 3.983560e-01 | 0.400 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.983560e-01 | 0.400 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.983560e-01 | 0.400 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.410298e-01 | 0.618 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 3.321155e-01 | 0.479 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.321155e-01 | 0.479 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.321155e-01 | 0.479 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.321155e-01 | 0.479 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.862407e-01 | 0.543 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.862407e-01 | 0.543 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.510066e-01 | 0.600 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.224460e-01 | 0.653 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.224460e-01 | 0.653 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.224460e-01 | 0.653 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.248932e-01 | 0.648 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.879841e-01 | 0.541 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.879841e-01 | 0.541 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.879841e-01 | 0.541 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.879841e-01 | 0.541 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.879841e-01 | 0.541 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.879841e-01 | 0.541 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.320330e-01 | 0.479 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.320330e-01 | 0.479 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.924875e-01 | 0.406 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.924875e-01 | 0.406 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.924875e-01 | 0.406 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.924875e-01 | 0.406 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.924875e-01 | 0.406 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.924875e-01 | 0.406 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.924875e-01 | 0.406 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.924875e-01 | 0.406 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.924875e-01 | 0.406 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.522776e-01 | 0.598 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.495404e-01 | 0.603 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.805184e-01 | 0.552 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.777143e-01 | 0.423 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 3.777143e-01 | 0.423 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.777143e-01 | 0.423 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.176997e-01 | 0.498 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.176997e-01 | 0.498 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.750632e-01 | 0.561 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.750632e-01 | 0.561 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.094190e-01 | 0.509 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.094190e-01 | 0.509 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.635832e-01 | 0.439 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.012147e-01 | 0.521 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.574738e-01 | 0.589 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.506422e-01 | 0.455 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.506422e-01 | 0.455 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.387845e-01 | 0.470 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.227028e-01 | 0.374 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.781539e-01 | 0.556 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.014245e-01 | 0.396 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.014245e-01 | 0.396 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.837393e-01 | 0.416 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.837393e-01 | 0.416 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.908996e-01 | 0.536 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.548194e-01 | 0.450 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.548194e-01 | 0.450 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.548194e-01 | 0.450 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.338249e-01 | 0.631 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.214753e-01 | 0.493 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.675954e-01 | 0.435 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.819858e-01 | 0.418 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.981605e-01 | 0.400 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.981605e-01 | 0.400 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.167515e-01 | 0.380 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.167515e-01 | 0.380 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.388397e-01 | 0.358 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.114361e-01 | 0.507 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.928186e-01 | 0.406 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.278185e-01 | 0.369 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.278185e-01 | 0.369 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.900435e-01 | 0.409 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.371117e-01 | 0.359 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.331361e-01 | 0.363 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.513932e-01 | 0.600 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.900435e-01 | 0.409 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.387995e-01 | 0.470 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.819858e-01 | 0.418 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.092113e-01 | 0.388 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.805184e-01 | 0.552 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.914891e-01 | 0.407 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.533248e-01 | 0.596 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.908996e-01 | 0.536 | 1 | 1 |
| Activation of SMO | R-HSA-5635838 | 4.388397e-01 | 0.358 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.316960e-01 | 0.479 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.278185e-01 | 0.369 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.208875e-01 | 0.376 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.176997e-01 | 0.498 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.506422e-01 | 0.455 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.510066e-01 | 0.600 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.224460e-01 | 0.653 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.851699e-01 | 0.545 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.908996e-01 | 0.536 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.214753e-01 | 0.493 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.256459e-01 | 0.487 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.224460e-01 | 0.653 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.256459e-01 | 0.487 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.777143e-01 | 0.423 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.176997e-01 | 0.498 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.853986e-01 | 0.545 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.015385e-01 | 0.521 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.879841e-01 | 0.541 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.533248e-01 | 0.596 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.851699e-01 | 0.545 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.851699e-01 | 0.545 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.386150e-01 | 0.358 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.026540e-01 | 0.519 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.459247e-01 | 0.609 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 2.410298e-01 | 0.618 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.410298e-01 | 0.618 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.224460e-01 | 0.653 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.924875e-01 | 0.406 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.851699e-01 | 0.545 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.635832e-01 | 0.439 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.513932e-01 | 0.600 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.167515e-01 | 0.380 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.638330e-01 | 0.439 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.913478e-01 | 0.407 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.484949e-01 | 0.605 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.410298e-01 | 0.618 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.216393e-01 | 0.375 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.283657e-01 | 0.641 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.934884e-01 | 0.532 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.966609e-01 | 0.402 | 1 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.862407e-01 | 0.543 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.247914e-01 | 0.648 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.750632e-01 | 0.561 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.235919e-01 | 0.651 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.014245e-01 | 0.396 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.424582e-01 | 0.615 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.020460e-01 | 0.520 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.784247e-01 | 0.555 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.073413e-01 | 0.390 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 4.278185e-01 | 0.369 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.811942e-01 | 0.419 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.278484e-01 | 0.484 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.312509e-01 | 0.480 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.580903e-01 | 0.588 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.943334e-01 | 0.531 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.544113e-01 | 0.594 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.873150e-01 | 0.542 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.338774e-01 | 0.631 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.338249e-01 | 0.631 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.570686e-01 | 0.447 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.909337e-01 | 0.536 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.981605e-01 | 0.400 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 2.829484e-01 | 0.548 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.981605e-01 | 0.400 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.981605e-01 | 0.400 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.527127e-01 | 0.453 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.701589e-01 | 0.568 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.207894e-01 | 0.656 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.060772e-01 | 0.514 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.879779e-01 | 0.411 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.387845e-01 | 0.470 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.666676e-01 | 0.574 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.516621e-01 | 0.599 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.400372e-01 | 0.620 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.861046e-01 | 0.413 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.246057e-01 | 0.649 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.870158e-01 | 0.412 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.900435e-01 | 0.409 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.208357e-01 | 0.494 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.900435e-01 | 0.409 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.900435e-01 | 0.409 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.496504e-01 | 0.456 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.713603e-01 | 0.566 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.400372e-01 | 0.620 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.073413e-01 | 0.390 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.873150e-01 | 0.542 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.701589e-01 | 0.568 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.983560e-01 | 0.400 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.983560e-01 | 0.400 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.983560e-01 | 0.400 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.983560e-01 | 0.400 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.321155e-01 | 0.479 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 3.321155e-01 | 0.479 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.321155e-01 | 0.479 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.862407e-01 | 0.543 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.510066e-01 | 0.600 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.320330e-01 | 0.479 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 3.924875e-01 | 0.406 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.232301e-01 | 0.651 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.777143e-01 | 0.423 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.373336e-01 | 0.625 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.633648e-01 | 0.579 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.506422e-01 | 0.455 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.227028e-01 | 0.374 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.227028e-01 | 0.374 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.297235e-01 | 0.639 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.992998e-01 | 0.524 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.908996e-01 | 0.536 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.306225e-01 | 0.481 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.384453e-01 | 0.623 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.363660e-01 | 0.360 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.882117e-01 | 0.411 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.073413e-01 | 0.390 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.805184e-01 | 0.552 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.206023e-01 | 0.656 | 1 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.443164e-01 | 0.612 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.522776e-01 | 0.598 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.425167e-01 | 0.465 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.316887e-01 | 0.365 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.787504e-01 | 0.555 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.379138e-01 | 0.624 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.855477e-01 | 0.544 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.227028e-01 | 0.374 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.247914e-01 | 0.648 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.312509e-01 | 0.480 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.410298e-01 | 0.618 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.321155e-01 | 0.479 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.014245e-01 | 0.396 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.908996e-01 | 0.536 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.350434e-01 | 0.475 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.522776e-01 | 0.598 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.853986e-01 | 0.545 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.214753e-01 | 0.493 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.384453e-01 | 0.623 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.545412e-01 | 0.450 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.176997e-01 | 0.498 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.082071e-01 | 0.511 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.837393e-01 | 0.416 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.943334e-01 | 0.531 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.983560e-01 | 0.400 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.983560e-01 | 0.400 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.983560e-01 | 0.400 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.855477e-01 | 0.544 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.020460e-01 | 0.520 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.388397e-01 | 0.358 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.692685e-01 | 0.570 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.635832e-01 | 0.439 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.235239e-01 | 0.490 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.777143e-01 | 0.423 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.533248e-01 | 0.596 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.082071e-01 | 0.511 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.312509e-01 | 0.480 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.312509e-01 | 0.480 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.545863e-01 | 0.450 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.404056e-01 | 0.619 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.833150e-01 | 0.548 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.316887e-01 | 0.365 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.924875e-01 | 0.406 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.924875e-01 | 0.406 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.417493e-01 | 0.617 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.633648e-01 | 0.579 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.633648e-01 | 0.579 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.555856e-01 | 0.592 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.093462e-01 | 0.388 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.093462e-01 | 0.388 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.082071e-01 | 0.511 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.611057e-01 | 0.442 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.101812e-01 | 0.508 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.267465e-01 | 0.370 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.227028e-01 | 0.374 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.246057e-01 | 0.649 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.781216e-01 | 0.422 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.642374e-01 | 0.578 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.642374e-01 | 0.578 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.781216e-01 | 0.422 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.418873e-01 | 0.355 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.432733e-01 | 0.353 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.432733e-01 | 0.353 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.460286e-01 | 0.351 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.461465e-01 | 0.351 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.490377e-01 | 0.348 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.490396e-01 | 0.348 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.494596e-01 | 0.347 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.498554e-01 | 0.347 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.499857e-01 | 0.347 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.502653e-01 | 0.347 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.502653e-01 | 0.347 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.502653e-01 | 0.347 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.502653e-01 | 0.347 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 4.502653e-01 | 0.347 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.502653e-01 | 0.347 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.565569e-01 | 0.341 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.633281e-01 | 0.334 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.649224e-01 | 0.333 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.665231e-01 | 0.331 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.665231e-01 | 0.331 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.665231e-01 | 0.331 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.665231e-01 | 0.331 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.665231e-01 | 0.331 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.665231e-01 | 0.331 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.665231e-01 | 0.331 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.685874e-01 | 0.329 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.725034e-01 | 0.326 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.755421e-01 | 0.323 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 4.755421e-01 | 0.323 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 4.755421e-01 | 0.323 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.755421e-01 | 0.323 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 4.786646e-01 | 0.320 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.793234e-01 | 0.319 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.816672e-01 | 0.317 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 4.816672e-01 | 0.317 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.862823e-01 | 0.313 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.862823e-01 | 0.313 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.862823e-01 | 0.313 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.892646e-01 | 0.310 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.899847e-01 | 0.310 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.899847e-01 | 0.310 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.899847e-01 | 0.310 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.912697e-01 | 0.309 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.921014e-01 | 0.308 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.921014e-01 | 0.308 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.921014e-01 | 0.308 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.921014e-01 | 0.308 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.921014e-01 | 0.308 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.921014e-01 | 0.308 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 4.921014e-01 | 0.308 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.921014e-01 | 0.308 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.921014e-01 | 0.308 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.921014e-01 | 0.308 | 0 | 0 |
| Defective ADA disrupts (deoxy)adenosine deamination | R-HSA-9734735 | 4.921014e-01 | 0.308 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.921014e-01 | 0.308 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 4.921014e-01 | 0.308 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.921014e-01 | 0.308 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.921014e-01 | 0.308 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.921014e-01 | 0.308 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.921014e-01 | 0.308 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.921014e-01 | 0.308 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.921014e-01 | 0.308 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.955769e-01 | 0.305 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.957500e-01 | 0.305 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.966876e-01 | 0.304 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.980999e-01 | 0.303 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.021147e-01 | 0.299 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 5.047919e-01 | 0.297 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.047919e-01 | 0.297 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.047919e-01 | 0.297 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.047919e-01 | 0.297 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.047919e-01 | 0.297 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.047919e-01 | 0.297 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.047919e-01 | 0.297 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 5.047919e-01 | 0.297 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 5.088000e-01 | 0.293 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 5.088000e-01 | 0.293 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.088000e-01 | 0.293 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.088000e-01 | 0.293 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.088000e-01 | 0.293 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.088000e-01 | 0.293 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.088000e-01 | 0.293 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.110244e-01 | 0.292 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.112885e-01 | 0.291 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 5.112885e-01 | 0.291 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.132015e-01 | 0.290 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.132015e-01 | 0.290 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.132015e-01 | 0.290 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.132015e-01 | 0.290 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.148120e-01 | 0.288 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.192792e-01 | 0.285 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.198192e-01 | 0.284 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.208658e-01 | 0.283 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.218590e-01 | 0.282 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.243973e-01 | 0.280 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.333163e-01 | 0.273 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.419784e-01 | 0.266 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.419784e-01 | 0.266 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.419784e-01 | 0.266 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.427141e-01 | 0.265 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.427141e-01 | 0.265 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.427141e-01 | 0.265 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.439132e-01 | 0.264 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.439594e-01 | 0.264 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.443286e-01 | 0.264 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.458577e-01 | 0.263 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.458779e-01 | 0.263 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.458779e-01 | 0.263 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.458779e-01 | 0.263 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.458779e-01 | 0.263 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.458779e-01 | 0.263 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.458779e-01 | 0.263 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.458779e-01 | 0.263 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 5.492481e-01 | 0.260 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.492481e-01 | 0.260 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.492481e-01 | 0.260 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.492481e-01 | 0.260 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.493975e-01 | 0.260 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.556777e-01 | 0.255 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.556777e-01 | 0.255 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 5.556777e-01 | 0.255 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.556777e-01 | 0.255 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 5.556777e-01 | 0.255 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.556777e-01 | 0.255 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.556777e-01 | 0.255 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.584991e-01 | 0.253 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.587430e-01 | 0.253 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.594148e-01 | 0.252 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.602201e-01 | 0.252 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.622908e-01 | 0.250 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.635098e-01 | 0.249 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.650823e-01 | 0.248 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.698877e-01 | 0.244 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.698877e-01 | 0.244 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.698877e-01 | 0.244 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.698877e-01 | 0.244 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.712444e-01 | 0.243 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.712444e-01 | 0.243 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.712444e-01 | 0.243 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.712444e-01 | 0.243 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 5.712444e-01 | 0.243 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.712444e-01 | 0.243 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.712444e-01 | 0.243 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.712444e-01 | 0.243 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.712444e-01 | 0.243 | 0 | 0 |
| Defective gamma-carboxylation of F9 | R-HSA-9673240 | 5.712444e-01 | 0.243 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 5.712444e-01 | 0.243 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.712444e-01 | 0.243 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.712444e-01 | 0.243 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.712444e-01 | 0.243 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.712444e-01 | 0.243 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.726020e-01 | 0.242 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.726020e-01 | 0.242 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.732366e-01 | 0.242 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.736764e-01 | 0.241 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.791494e-01 | 0.237 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.791494e-01 | 0.237 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.791494e-01 | 0.237 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.846161e-01 | 0.233 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.847115e-01 | 0.233 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.871099e-01 | 0.231 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.876622e-01 | 0.231 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.876622e-01 | 0.231 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.876622e-01 | 0.231 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.915705e-01 | 0.228 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.942038e-01 | 0.226 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.943520e-01 | 0.226 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.968432e-01 | 0.224 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.023877e-01 | 0.220 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.023877e-01 | 0.220 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.023877e-01 | 0.220 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.023877e-01 | 0.220 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.027335e-01 | 0.220 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.027335e-01 | 0.220 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.027335e-01 | 0.220 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.027335e-01 | 0.220 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 6.027335e-01 | 0.220 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.027335e-01 | 0.220 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.027335e-01 | 0.220 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.027335e-01 | 0.220 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.027335e-01 | 0.220 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.027335e-01 | 0.220 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.027335e-01 | 0.220 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.027335e-01 | 0.220 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.027335e-01 | 0.220 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.027335e-01 | 0.220 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.027335e-01 | 0.220 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.027335e-01 | 0.220 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.027335e-01 | 0.220 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.032755e-01 | 0.219 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.064548e-01 | 0.217 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.077961e-01 | 0.216 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.099224e-01 | 0.215 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.104644e-01 | 0.214 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.109792e-01 | 0.214 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.109792e-01 | 0.214 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.109792e-01 | 0.214 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.109792e-01 | 0.214 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.137737e-01 | 0.212 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.137737e-01 | 0.212 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.154266e-01 | 0.211 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.203978e-01 | 0.207 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.211631e-01 | 0.207 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.217193e-01 | 0.206 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.239061e-01 | 0.205 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.239061e-01 | 0.205 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.239061e-01 | 0.205 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.239061e-01 | 0.205 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.239061e-01 | 0.205 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.269689e-01 | 0.203 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.271156e-01 | 0.203 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.285958e-01 | 0.202 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.299651e-01 | 0.201 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.299651e-01 | 0.201 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.299651e-01 | 0.201 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.319979e-01 | 0.199 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.380587e-01 | 0.195 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.380587e-01 | 0.195 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 6.380587e-01 | 0.195 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 6.380587e-01 | 0.195 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 6.380587e-01 | 0.195 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 6.380587e-01 | 0.195 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 6.380587e-01 | 0.195 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.380587e-01 | 0.195 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.380587e-01 | 0.195 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 6.380587e-01 | 0.195 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 6.380587e-01 | 0.195 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 6.380587e-01 | 0.195 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.412776e-01 | 0.193 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.412776e-01 | 0.193 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.412776e-01 | 0.193 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.459173e-01 | 0.190 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.459173e-01 | 0.190 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.459173e-01 | 0.190 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.459173e-01 | 0.190 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.459173e-01 | 0.190 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.459173e-01 | 0.190 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.459173e-01 | 0.190 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.459173e-01 | 0.190 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.459173e-01 | 0.190 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.459173e-01 | 0.190 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.479693e-01 | 0.188 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.479693e-01 | 0.188 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.479693e-01 | 0.188 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.532626e-01 | 0.185 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.535478e-01 | 0.185 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.563465e-01 | 0.183 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.563465e-01 | 0.183 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.563465e-01 | 0.183 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.573243e-01 | 0.182 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.579025e-01 | 0.182 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.579025e-01 | 0.182 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.579025e-01 | 0.182 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.579025e-01 | 0.182 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.579025e-01 | 0.182 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.606361e-01 | 0.180 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.699850e-01 | 0.174 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.699850e-01 | 0.174 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.717033e-01 | 0.173 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.731729e-01 | 0.172 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.752843e-01 | 0.171 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.755390e-01 | 0.170 | 1 | 1 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.814880e-01 | 0.167 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.814880e-01 | 0.167 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.814880e-01 | 0.167 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.814880e-01 | 0.167 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.814880e-01 | 0.167 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.819858e-01 | 0.166 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.819858e-01 | 0.166 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.852930e-01 | 0.164 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.852930e-01 | 0.164 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.852930e-01 | 0.164 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.852930e-01 | 0.164 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.852930e-01 | 0.164 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.896227e-01 | 0.161 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.896227e-01 | 0.161 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.923054e-01 | 0.160 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.923054e-01 | 0.160 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.925295e-01 | 0.160 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.944644e-01 | 0.158 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.944644e-01 | 0.158 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.944644e-01 | 0.158 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.944644e-01 | 0.158 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.944644e-01 | 0.158 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.944644e-01 | 0.158 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.944644e-01 | 0.158 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 6.944644e-01 | 0.158 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.944644e-01 | 0.158 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.944644e-01 | 0.158 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.944644e-01 | 0.158 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.944644e-01 | 0.158 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.944644e-01 | 0.158 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.944644e-01 | 0.158 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.944644e-01 | 0.158 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 6.944644e-01 | 0.158 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.963540e-01 | 0.157 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.970686e-01 | 0.157 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 6.970686e-01 | 0.157 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.970686e-01 | 0.157 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.024630e-01 | 0.153 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.053623e-01 | 0.152 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.053623e-01 | 0.152 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.053623e-01 | 0.152 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.103439e-01 | 0.149 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.132577e-01 | 0.147 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.137802e-01 | 0.146 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.146580e-01 | 0.146 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.195237e-01 | 0.143 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 7.209987e-01 | 0.142 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.209987e-01 | 0.142 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.209987e-01 | 0.142 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.209987e-01 | 0.142 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.209987e-01 | 0.142 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.209987e-01 | 0.142 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.209987e-01 | 0.142 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.225188e-01 | 0.141 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.277048e-01 | 0.138 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.279570e-01 | 0.138 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.342006e-01 | 0.134 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.420824e-01 | 0.130 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.420824e-01 | 0.130 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 7.420824e-01 | 0.130 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 7.420824e-01 | 0.130 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.420824e-01 | 0.130 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 7.420824e-01 | 0.130 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.420824e-01 | 0.130 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 7.420824e-01 | 0.130 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 7.420824e-01 | 0.130 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.420824e-01 | 0.130 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.420824e-01 | 0.130 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 7.420824e-01 | 0.130 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.420824e-01 | 0.130 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.420824e-01 | 0.130 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 7.420824e-01 | 0.130 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 7.420824e-01 | 0.130 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.420824e-01 | 0.130 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.420824e-01 | 0.130 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 7.420824e-01 | 0.130 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 7.420824e-01 | 0.130 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.420824e-01 | 0.130 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.420824e-01 | 0.130 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.463115e-01 | 0.127 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.463115e-01 | 0.127 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.463454e-01 | 0.127 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.463454e-01 | 0.127 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.473403e-01 | 0.126 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.492726e-01 | 0.125 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.523350e-01 | 0.124 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.532218e-01 | 0.123 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.532218e-01 | 0.123 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.532218e-01 | 0.123 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.532218e-01 | 0.123 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.532218e-01 | 0.123 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.532218e-01 | 0.123 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.532218e-01 | 0.123 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.532218e-01 | 0.123 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.578175e-01 | 0.120 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.595889e-01 | 0.119 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.602490e-01 | 0.119 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.657392e-01 | 0.116 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.681410e-01 | 0.115 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.693210e-01 | 0.114 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.713911e-01 | 0.113 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.713911e-01 | 0.113 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.713911e-01 | 0.113 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.713911e-01 | 0.113 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.713911e-01 | 0.113 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.713911e-01 | 0.113 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.725174e-01 | 0.112 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.738344e-01 | 0.111 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.741066e-01 | 0.111 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.781146e-01 | 0.109 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.821805e-01 | 0.107 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.821805e-01 | 0.107 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.821805e-01 | 0.107 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.821805e-01 | 0.107 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.821805e-01 | 0.107 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.821805e-01 | 0.107 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.821805e-01 | 0.107 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.821805e-01 | 0.107 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.821805e-01 | 0.107 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.821805e-01 | 0.107 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.822814e-01 | 0.107 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 7.822814e-01 | 0.107 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.822814e-01 | 0.107 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.822814e-01 | 0.107 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 7.822814e-01 | 0.107 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.822814e-01 | 0.107 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 7.822814e-01 | 0.107 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.822814e-01 | 0.107 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 7.822814e-01 | 0.107 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.822814e-01 | 0.107 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.822814e-01 | 0.107 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.822814e-01 | 0.107 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.822814e-01 | 0.107 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.829125e-01 | 0.106 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.853467e-01 | 0.105 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.891538e-01 | 0.103 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.891538e-01 | 0.103 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.891538e-01 | 0.103 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.892478e-01 | 0.103 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.892478e-01 | 0.103 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.892478e-01 | 0.103 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.911968e-01 | 0.102 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.914202e-01 | 0.102 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.931698e-01 | 0.101 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.944253e-01 | 0.100 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.005611e-01 | 0.097 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.054116e-01 | 0.094 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.054116e-01 | 0.094 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.054116e-01 | 0.094 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.054116e-01 | 0.094 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.054116e-01 | 0.094 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.054116e-01 | 0.094 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.057106e-01 | 0.094 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.057106e-01 | 0.094 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.060559e-01 | 0.094 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.065466e-01 | 0.093 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.081093e-01 | 0.093 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.081093e-01 | 0.093 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.081093e-01 | 0.093 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.081093e-01 | 0.093 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.084142e-01 | 0.092 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.084142e-01 | 0.092 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.084142e-01 | 0.092 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.084142e-01 | 0.092 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.085757e-01 | 0.092 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.085757e-01 | 0.092 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.111762e-01 | 0.091 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.148488e-01 | 0.089 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.154479e-01 | 0.089 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.154479e-01 | 0.089 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.154479e-01 | 0.089 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.154479e-01 | 0.089 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.154479e-01 | 0.089 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.154479e-01 | 0.089 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.154992e-01 | 0.089 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.162170e-01 | 0.088 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 8.162170e-01 | 0.088 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 8.162170e-01 | 0.088 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.162170e-01 | 0.088 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 8.162170e-01 | 0.088 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 8.162170e-01 | 0.088 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.162170e-01 | 0.088 | 0 | 0 |
| Reuptake of GABA | R-HSA-888593 | 8.162170e-01 | 0.088 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 8.162170e-01 | 0.088 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 8.162170e-01 | 0.088 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.162170e-01 | 0.088 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 8.162170e-01 | 0.088 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 8.162170e-01 | 0.088 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 8.162170e-01 | 0.088 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.213368e-01 | 0.085 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.221177e-01 | 0.085 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.221177e-01 | 0.085 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.261336e-01 | 0.083 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.261336e-01 | 0.083 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.261336e-01 | 0.083 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.261336e-01 | 0.083 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.286729e-01 | 0.082 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.312492e-01 | 0.080 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.312492e-01 | 0.080 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.312492e-01 | 0.080 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.312492e-01 | 0.080 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.312492e-01 | 0.080 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.312492e-01 | 0.080 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.312492e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.312492e-01 | 0.080 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.312492e-01 | 0.080 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.312492e-01 | 0.080 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.336335e-01 | 0.079 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.340242e-01 | 0.079 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.342485e-01 | 0.079 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.346322e-01 | 0.079 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.346322e-01 | 0.079 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.346338e-01 | 0.079 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.346338e-01 | 0.079 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.349750e-01 | 0.078 | 0 | 0 |
| RSK activation | R-HSA-444257 | 8.448646e-01 | 0.073 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.448646e-01 | 0.073 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.448646e-01 | 0.073 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 8.448646e-01 | 0.073 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.448646e-01 | 0.073 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.448646e-01 | 0.073 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 8.448646e-01 | 0.073 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.448646e-01 | 0.073 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.448646e-01 | 0.073 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.448646e-01 | 0.073 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 8.448646e-01 | 0.073 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 8.448646e-01 | 0.073 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 8.448646e-01 | 0.073 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 8.448646e-01 | 0.073 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.465739e-01 | 0.072 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.483419e-01 | 0.071 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.483419e-01 | 0.071 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.518394e-01 | 0.070 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.518394e-01 | 0.070 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.518394e-01 | 0.070 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.518394e-01 | 0.070 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.518394e-01 | 0.070 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.520751e-01 | 0.070 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.520751e-01 | 0.070 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.520751e-01 | 0.070 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.520751e-01 | 0.070 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.557235e-01 | 0.068 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.574965e-01 | 0.067 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.580169e-01 | 0.067 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.603864e-01 | 0.065 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.690481e-01 | 0.061 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.690481e-01 | 0.061 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.690481e-01 | 0.061 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.690481e-01 | 0.061 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 8.690481e-01 | 0.061 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.690481e-01 | 0.061 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.690481e-01 | 0.061 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.696527e-01 | 0.061 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.701125e-01 | 0.060 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.701125e-01 | 0.060 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.701125e-01 | 0.060 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.701125e-01 | 0.060 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.701125e-01 | 0.060 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.701125e-01 | 0.060 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.701125e-01 | 0.060 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.701125e-01 | 0.060 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 8.701125e-01 | 0.060 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.701820e-01 | 0.060 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.709568e-01 | 0.060 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.712821e-01 | 0.060 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.724213e-01 | 0.059 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.741580e-01 | 0.058 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.773882e-01 | 0.057 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.780373e-01 | 0.056 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.798916e-01 | 0.056 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.821902e-01 | 0.054 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.821902e-01 | 0.054 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 8.839016e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.857303e-01 | 0.053 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.862009e-01 | 0.052 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.862904e-01 | 0.052 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.862904e-01 | 0.052 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.862904e-01 | 0.052 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 8.862904e-01 | 0.052 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.862904e-01 | 0.052 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.862904e-01 | 0.052 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.862904e-01 | 0.052 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.894629e-01 | 0.051 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.894629e-01 | 0.051 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.894629e-01 | 0.051 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.894629e-01 | 0.051 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.944998e-01 | 0.048 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.950951e-01 | 0.048 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.950951e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.950951e-01 | 0.048 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.950951e-01 | 0.048 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.953300e-01 | 0.048 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.983528e-01 | 0.047 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.986449e-01 | 0.046 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.994969e-01 | 0.046 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.005821e-01 | 0.045 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.005821e-01 | 0.045 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.005821e-01 | 0.045 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.005821e-01 | 0.045 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.011369e-01 | 0.045 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.059371e-01 | 0.043 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 9.066961e-01 | 0.043 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 9.066961e-01 | 0.043 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 9.066961e-01 | 0.043 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 9.066961e-01 | 0.043 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 9.066961e-01 | 0.043 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 9.066961e-01 | 0.043 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 9.066961e-01 | 0.043 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 9.066961e-01 | 0.043 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 9.066961e-01 | 0.043 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.067144e-01 | 0.043 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.067144e-01 | 0.043 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.131825e-01 | 0.039 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.131825e-01 | 0.039 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.131825e-01 | 0.039 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.131825e-01 | 0.039 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.131825e-01 | 0.039 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.131825e-01 | 0.039 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.131825e-01 | 0.039 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.133844e-01 | 0.039 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.145847e-01 | 0.039 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.149140e-01 | 0.039 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.154977e-01 | 0.038 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.154977e-01 | 0.038 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.154977e-01 | 0.038 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.154977e-01 | 0.038 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.165275e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.165275e-01 | 0.038 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.165275e-01 | 0.038 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.168504e-01 | 0.038 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.171549e-01 | 0.038 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.189540e-01 | 0.037 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.189540e-01 | 0.037 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.193062e-01 | 0.037 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.210438e-01 | 0.036 | 1 | 0 |
| Gamma-carboxylation of protein precursors | R-HSA-159740 | 9.212434e-01 | 0.036 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 9.212434e-01 | 0.036 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 9.212434e-01 | 0.036 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 9.212434e-01 | 0.036 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 9.212434e-01 | 0.036 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.212434e-01 | 0.036 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 9.212434e-01 | 0.036 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.212434e-01 | 0.036 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 9.212434e-01 | 0.036 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 9.212434e-01 | 0.036 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.221105e-01 | 0.035 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.242715e-01 | 0.034 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.242715e-01 | 0.034 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.242715e-01 | 0.034 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.242715e-01 | 0.034 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.242715e-01 | 0.034 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.243424e-01 | 0.034 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.252323e-01 | 0.034 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.265184e-01 | 0.033 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.287719e-01 | 0.032 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.298023e-01 | 0.032 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.317737e-01 | 0.031 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.320516e-01 | 0.031 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 9.335233e-01 | 0.030 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 9.335233e-01 | 0.030 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 9.335233e-01 | 0.030 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.335233e-01 | 0.030 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 9.335233e-01 | 0.030 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.335233e-01 | 0.030 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.335233e-01 | 0.030 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.335233e-01 | 0.030 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.335233e-01 | 0.030 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.340139e-01 | 0.030 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.340139e-01 | 0.030 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.340139e-01 | 0.030 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.347096e-01 | 0.029 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.347096e-01 | 0.029 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.349009e-01 | 0.029 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.349009e-01 | 0.029 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.349009e-01 | 0.029 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.391756e-01 | 0.027 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.400876e-01 | 0.027 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.406129e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.425601e-01 | 0.026 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.425601e-01 | 0.026 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.425601e-01 | 0.026 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.426275e-01 | 0.026 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.438891e-01 | 0.025 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 9.438891e-01 | 0.025 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.438891e-01 | 0.025 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.438891e-01 | 0.025 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.438891e-01 | 0.025 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.438891e-01 | 0.025 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.438891e-01 | 0.025 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.438891e-01 | 0.025 | 1 | 1 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.438891e-01 | 0.025 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.438891e-01 | 0.025 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.438891e-01 | 0.025 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.438891e-01 | 0.025 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.438891e-01 | 0.025 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.444810e-01 | 0.025 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.444810e-01 | 0.025 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.444810e-01 | 0.025 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.456128e-01 | 0.024 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.456128e-01 | 0.024 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.458523e-01 | 0.024 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.490772e-01 | 0.023 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.490772e-01 | 0.023 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.494134e-01 | 0.023 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.498114e-01 | 0.022 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.500461e-01 | 0.022 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.500461e-01 | 0.022 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.500461e-01 | 0.022 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.500461e-01 | 0.022 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.526390e-01 | 0.021 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.526390e-01 | 0.021 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.526390e-01 | 0.021 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.526390e-01 | 0.021 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.526390e-01 | 0.021 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 9.526390e-01 | 0.021 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 9.526390e-01 | 0.021 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 9.526390e-01 | 0.021 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.526390e-01 | 0.021 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.526390e-01 | 0.021 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.526390e-01 | 0.021 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.539702e-01 | 0.020 | 1 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.561028e-01 | 0.019 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.565948e-01 | 0.019 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.565948e-01 | 0.019 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.565948e-01 | 0.019 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.565948e-01 | 0.019 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.565948e-01 | 0.019 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.565948e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.566530e-01 | 0.019 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.566530e-01 | 0.019 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.566530e-01 | 0.019 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.572028e-01 | 0.019 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.587957e-01 | 0.018 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.600249e-01 | 0.018 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.600249e-01 | 0.018 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.600249e-01 | 0.018 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.600249e-01 | 0.018 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.600249e-01 | 0.018 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.603315e-01 | 0.018 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.603325e-01 | 0.018 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.613604e-01 | 0.017 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.623162e-01 | 0.017 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.623162e-01 | 0.017 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.623162e-01 | 0.017 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.623162e-01 | 0.017 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.623162e-01 | 0.017 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.650390e-01 | 0.015 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.650390e-01 | 0.015 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.650390e-01 | 0.015 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.655896e-01 | 0.015 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.655896e-01 | 0.015 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.655896e-01 | 0.015 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.662593e-01 | 0.015 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.662593e-01 | 0.015 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.662593e-01 | 0.015 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.662593e-01 | 0.015 | 0 | 0 |
| Carnitine synthesis | R-HSA-71262 | 9.662593e-01 | 0.015 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.662593e-01 | 0.015 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.662593e-01 | 0.015 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.662593e-01 | 0.015 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.662593e-01 | 0.015 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.662593e-01 | 0.015 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.672398e-01 | 0.014 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.691800e-01 | 0.014 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.692161e-01 | 0.014 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.692161e-01 | 0.014 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.693845e-01 | 0.014 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.697917e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.697917e-01 | 0.013 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.715218e-01 | 0.013 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.715218e-01 | 0.013 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.715218e-01 | 0.013 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.715218e-01 | 0.013 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.715218e-01 | 0.013 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.715218e-01 | 0.013 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.716618e-01 | 0.012 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.727694e-01 | 0.012 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.727694e-01 | 0.012 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.727694e-01 | 0.012 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.727854e-01 | 0.012 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.729178e-01 | 0.012 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.751508e-01 | 0.011 | 1 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.752325e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.754523e-01 | 0.011 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.754523e-01 | 0.011 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.754741e-01 | 0.011 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.758296e-01 | 0.011 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.758296e-01 | 0.011 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.759637e-01 | 0.011 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.759637e-01 | 0.011 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.759637e-01 | 0.011 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.759637e-01 | 0.011 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.761945e-01 | 0.010 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.761945e-01 | 0.010 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.773447e-01 | 0.010 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.785515e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.785957e-01 | 0.009 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.787500e-01 | 0.009 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.797130e-01 | 0.009 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.797130e-01 | 0.009 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.797130e-01 | 0.009 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.797130e-01 | 0.009 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.801766e-01 | 0.009 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.809824e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.816164e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.816507e-01 | 0.008 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.828776e-01 | 0.008 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.828776e-01 | 0.008 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.829515e-01 | 0.007 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.831512e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.839085e-01 | 0.007 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.850841e-01 | 0.007 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.855487e-01 | 0.006 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 9.855487e-01 | 0.006 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.858265e-01 | 0.006 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.862661e-01 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.862661e-01 | 0.006 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.871220e-01 | 0.006 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.871838e-01 | 0.006 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.872621e-01 | 0.006 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.878033e-01 | 0.005 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.878033e-01 | 0.005 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.878033e-01 | 0.005 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.878033e-01 | 0.005 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.878033e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.878045e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.881394e-01 | 0.005 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.881843e-01 | 0.005 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.883361e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.891937e-01 | 0.005 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.891937e-01 | 0.005 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.897062e-01 | 0.004 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.897062e-01 | 0.004 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.897062e-01 | 0.004 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.897062e-01 | 0.004 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.897062e-01 | 0.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.897587e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.901007e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.902437e-01 | 0.004 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.906470e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.913028e-01 | 0.004 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.913123e-01 | 0.004 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.913123e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.916871e-01 | 0.004 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.919061e-01 | 0.004 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.921100e-01 | 0.003 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.926679e-01 | 0.003 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.926679e-01 | 0.003 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.926679e-01 | 0.003 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.926679e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.934361e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.934361e-01 | 0.003 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.935581e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.936018e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.938348e-01 | 0.003 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.939175e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.943935e-01 | 0.002 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.945054e-01 | 0.002 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.945054e-01 | 0.002 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.945054e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.947777e-01 | 0.002 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.947777e-01 | 0.002 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.947777e-01 | 0.002 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.947777e-01 | 0.002 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.947777e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.951304e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.951304e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.951304e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.951304e-01 | 0.002 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.952559e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.954335e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.955108e-01 | 0.002 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.955928e-01 | 0.002 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.955928e-01 | 0.002 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.955928e-01 | 0.002 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.955928e-01 | 0.002 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.955928e-01 | 0.002 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.956368e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.958245e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.958245e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.962296e-01 | 0.002 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.962675e-01 | 0.002 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.962806e-01 | 0.002 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.962806e-01 | 0.002 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.962806e-01 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.962998e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.963934e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.963934e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.968350e-01 | 0.001 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.968611e-01 | 0.001 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.968611e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.968979e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.972022e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.972446e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.972446e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.972446e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.973328e-01 | 0.001 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.973511e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.975281e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.977076e-01 | 0.001 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.977646e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.979165e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.979589e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.979589e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.980304e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.980735e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.982842e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.983083e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.984361e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.984672e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.985093e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.985474e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.986566e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.986566e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.987302e-01 | 0.001 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.988664e-01 | 0.000 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.988664e-01 | 0.000 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.988664e-01 | 0.000 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.988664e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.988755e-01 | 0.000 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.990434e-01 | 0.000 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.990434e-01 | 0.000 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.990434e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.990821e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.991084e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.991524e-01 | 0.000 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.991928e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.991928e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.992212e-01 | 0.000 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.992271e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.993188e-01 | 0.000 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.993188e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.994180e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.994215e-01 | 0.000 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.994252e-01 | 0.000 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.994252e-01 | 0.000 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.994252e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.994347e-01 | 0.000 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.995150e-01 | 0.000 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.995150e-01 | 0.000 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.995150e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.995568e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.995815e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.996547e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997063e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997185e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.997333e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.997773e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.997795e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.998249e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998430e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.998430e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998430e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.998523e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998645e-01 | 0.000 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.998754e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.998954e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.999113e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999129e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999164e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999236e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999347e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.999368e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999513e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.999550e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999652e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.999652e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999772e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999778e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.999789e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.999838e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999876e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999880e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999891e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999901e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999939e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999941e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999945e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999951e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999970e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999970e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999976e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999976e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999983e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999983e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999985e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999986e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999988e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999995e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999995e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999996e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999997e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999997e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |